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SUMMARY 
 
 
 
Introduction:  The relationship between Periodontal Disease and Type II 
diabetes has been reported in recent literature.  More recent studies suggest 
that further research is required into the relationship of glycaemic control on 
Periodontitis. 
   
 The main aetiological factor in Periodontal Disease is plaque, however other 
secondary factors such as Diabetes Mellitus, neutrophil abnormalities, 
smoking, socio-economic status, age, stress, Human Immunodeficiency Virus 
(HIV) infections, pregnancy, sex hormones, osteoporosis and several other 
conditions play an important causative role (Genco, 1993).   
 
Aim:  The purpose of this study is to test the hypothesis that the prevalence 
and severity of periodontal disease is greater for patients with poorly controlled 
Type II Diabetes Mellitus (DM-2) compared to those with better controlled Type 
II Diabetes Mellitus.      
 
Methods:  „Coloured female patients‘, who were diagnosed with Type II 
diabetes were included in the study. Demographic information, medical history 
and HbA1c levels were recorded by the attending physician in the diabetes 
unit. Periodontal examination was carried out by a single examiner.  This 
included a plaque index (PI), a gingival index (GI), bleeding on probing (BoP), 
probing depths (PD) and clinical attachment loss (CAL). These measurements 
were recorded on Ramfjord teeth. The presence of any one sextant showing 
PD of ≥ 4 mm or clinical loss of attachment of ≥ 3 mm was diagnosed as 
periodontitis. 
 
Results:  Poor glycaemic control was associated with more severe 
periodontitis. 
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Conclusion: The results of the study showed that it could be justified that the 
regression approach (correlation) be applied to the complete sample of 63 
individuals.  Most of these correlation coefficients were positive and 
significantly different from zero, indicating that ―HbA1c‖ had a detrimental 
influence on the periodontal measurements; within the limitations of the study.  
This link could be indirect in that some other properties of diabetes, and not 
necessarily ―HbA1c‖, affected the dental health of diabetics adversely. 
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GLOSSARY, DEFINITIONS and ABBREVIATIONS 
 
Risk is the probability that an individual will get a specific disease in a given 
period.  The risk of developing the disease will vary from individual to individual.   
 
Risk factors may be environmental, behavioural, or biological factors that, 
when present, increase the likelihood that an individual will get the disease.  
Risk factors are identified through longitudinal studies of patients with the 
disease of interest.  
 
HbA1c- Haemoglobin A1c (HbA1c) is a minor component of haemoglobin to 
which glucose is bound. HbA1c also is referred to as glycosylated or 
glucosylated haemoglobin. 
  
Glycaeted haemoglobin assay, measures the amount of glucose irreversibly 
bound to the haemoglobin molecule.  
 
Casual plasma glucose concentration- ‗Casual‘ is defined as any time of the 
day without regard to the time since the last meal. 
 
 Fasting plasma glucose- Fasting is defined as no caloric intake for at least 8 
hours. 
 
CI   —  Calculus Index 
 
DM  —  Diabetes Mellitus 
 
GI   —  Gingival Index 
  
PD  —  Periodontal Disease 
 
PI  —  Periodontal Index 
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CHAPTER 1 
 
INTRODUCTION 
 
 
 The motivation for this study is outlined in this chapter.  The relationship 
between Periodontal Disease and Type II Diabetes has been researched, 
however it has been suggested in previous studies that the relationship of 
glycaemic control and periodontitis needs further elucidation (Navarro-Sanchez 
et al., 2007; Promsudthi et al., 2005; Kiran et al., 2005; Tsai et al., 2002).  
  
 Various factors predispose individuals to periodontal disease.  These include 
Diabetes Mellitus, neutrophil abnormalities, smoking, socio-economic status, 
age, stress, Human Immunodeficiency Virus (HIV) infections, pregnancy, 
osteoporosis as well as race (Van Dyke & Dave, 2005; Genco, 1993).  The 
association between periodontal disease and systemic conditions such as 
diabetes and cardiovascular disease has been explored in several studies, 
(Faria-Almeida et al., 2006; Southerland et al., 2006; Genco et al., 2005; Geerts 
et al., 2004; Teng et al., 2002).  It has been established that periodontal disease 
is more prevalent and more severe in persons with diabetes than in non-diabetic 
persons.  Indeed, periodontal disease has been recognized for some time as the 
"sixth complication" of diabetes (Loe, 1993). 
 
 The current classification of Diabetes Mellitus is based upon the 
pathophysiology of each form of the disease (Mealey & Oates, 2006; American 
Diabetes Association, 2005). 
 
 Type I diabetes results from cellular mediated auto-immune destruction of 
pancreatic ß-cells, usually leading to a total cessation of insulin secretion.  
Markers of autoimmune destruction have been identified and can be used for 
diagnosis or risk assessment (American Diabetes Association, 2005).  Type I 
diabetes usually presents in children and adolescents, although some studies 
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demonstrated 15% to 30% of all cases being diagnosed after 30 years of age, 
(Laakso, 1985).  In older Type I patients, the ß-cell destruction occurs more 
slowly than in children, with a less abrupt onset of symptoms.  This indicates that 
the rate and the extent of cellular destruction may vary between patients.  The 
lack of insulin production in patients with Type I diabetes makes the use of 
exogenous insulin necessary to sustain life, hence the former name ―insulin-
dependent diabetes,‖ (American Diabetes Association, 2005).  In the absence of 
insulin these patients develop ketoacidosis, a life-threatening complication.   
 
 Type II diabetes, previously called ―non-insulin-dependent diabetes‖, results 
from insulin resistance, which alters the use of endogenously produced insulin at 
the target cells (American Diabetes Association, 2005). People affected by Type 
II diabetes have altered insulin production without destruction of ß-cells, and they 
retain the capacity for some insulin production.  The presence of insulin (however 
minimal) in the latter group of individuals results in a lower occurrence of 
ketoacidosis compared to the Type I group.  Type II patients can remain 
undiagnosed for many years because the hyperglycaemia appears gradually and 
often without symptoms, (DeFronzo & Ferrannini, 1991).  Often, especially early 
in the disease process, pancreatic insulin production increases to compensate 
for insulin resistance.  As the condition progresses, pancreatic insulin production 
diminishes due to the prolonged increase in secretory demand  (Mealey & Oates, 
2006). Insulin secretion becomes insufficient to compensate for insulin 
resistance.  Although Type II diabetics do not always necessarily need insulin to 
survive, insulin may be used as part of the medical management of Type II 
diabetes.  About 90% of affected persons are affected by Type II diabetes. 
 
 The impact of Diabetes Mellitus on the oral cavity has been well researched, 
and there is strong evidence demonstrating that diabetes is a risk factor for 
gingivitis and periodontitis (Mealey & Ocampo, 2007; Southerland et al., 2006).  
The degree of glycaemic control is an important variable in the bi-directional 
relationship between diabetes and periodontal diseases.  A higher prevalence 
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and severity of periodontal disease is seen in individuals with poor glycaemic 
control.  Significant improvements in both glycaemic control and periodontal 
condition may be achieved by the implementation of periodontal therapy (Garcia, 
2007; Mealey & Ocampo, 2007; Navarro-Sanchez et al., 2007; Promsudthi et al., 
2005; Kiran et al., 2005).  Large epidemiological studies have shown that 
diabetes increases the risk of alveolar bone loss and attachment loss 
approximately three-fold when compared to non-diabetic individuals (Mealey & 
Ocampo, 2007).  Tsai, Hayes & Taylor (2002) found the degree of glycaemic 
control to be the major factor affecting the risk of periodontal disease.  In a large 
epidemiological study, the authors reported that adults with poorly controlled 
Diabetes Mellitus had a 2.9-fold increased risk of having periodontitis compared 
to non-diabetic patients; conversely, patients with well-controlled Diabetes 
Mellitus had no significant increase in the risk for periodontitis.  
  
 Various parameters over the years have been used to investigate the level of 
glycaemic control in Diabetes Mellitus.  These include haemoglobin A1 (HbA1), 
(Taylor et al., 1998), haemoglobin A1c (HbA1c), (Tsai et al., 2002) and random 
blood sugar (RBS), (Almas et al., 2001).  According to the American Diabetes 
Association (2005) glycaeted haemoglobin assay measures the amount of 
glucose irreversibly bound to the haemoglobin molecule.  This bound glucose 
value is proportional to blood glucose levels.  Glycaeted haemoglobin (HbA1c) 
records the serum glucose level over 2-3 months (American Diabetes 
Association, 2005).  
 
 In 1998, the WHO revised the diagnostic criteria for diabetes, and introduced 
the concept of impaired fasting glycaemia (IFG).  More recently, the American 
Diabetes Association (ADA), 2005, proposed the upper limit of normal for fasting 
plasma glucose be lowered from 6.1 to 5.6mmol/l.    
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 The aim of this study is to investigate the prevalence and severity of 
periodontal disease in Type II diabetics, compared to a control group of non-
diabetics.  This literature review will pay special attention to HbA1c levels and its 
relationship with the prevalence and severity of periodontal disease.  The 
purpose of this study is to test the hypothesis that, ‗the prevalence and severity 
of periodontal disease is greater, for patients with poorly controlled Type II 
Diabetes Mellitus compared to those who are better controlled.  Diabetic control 
will be monitored by using HbA1c readings which are recorded.    
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CHAPTER 2 
 
LITERATURE REVIEW 
 
2.1 Definition of Diabetes Mellitus 
 
 Diabetes Mellitus is one of the most common endocrine disorders resulting 
from relative or absolute deficiency of insulin and is characterized by persistently 
raised blood glucose levels (hyperglycaemia).  Diabetes, coronary heart disease 
and adult periodontitis are common chronic diseases observed in a significant 
proportion of the adult South African population.  Diabetes is a metabolic disease 
that, due to disturbances in insulin production, leads to abnormal fat, sugar, and 
protein metabolism and resultant hyperglycaemia that can ultimately induce 
diverse multiple system pathologies (Winer and Sowers, 2004).  The classic 
symptoms of diabetes include polyuria, polydipsia, and unexplained weight loss. 
   
 Literature that elucidates the relationship between periodontal disease and 
Type II diabetes, in particular, studies in which glycaemic control was monitored, 
by measuring HbA1c are reviewed in this chapter. 
 
 
2.2 Risk Factors for Type II Diabetes  
  
1. Genetic predisposition to diabetes. 
2. Obesity. 
3. Lack of exercise. 
4. Gestational diabetes. 
5. Pre-diabetes. 
6. Ageing. 
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2.3 Epidemiology  
 
 Diabetes Mellitus (DM) is a chronic metabolic disorder that was reported to 
affect more than 100 million people worldwide in 1998.  This number is expected 
to treble by year 2025 (Alberti & Zimmet, 1998).  Hough, (2007) reported that, the 
prevalence of Type II Diabetes Mellitus is more than 200 million, currently.  
Moreover, the incidence of Type II diabetes is predicted to increase by 30-70% in 
Europe and the USA in the next 15-20 years, (Hough, 2007).   
 
 The prevalence of Diabetes Mellitus in South Africans was reported using 
epidemiological data from KwaZulu-Natal (Motala, Omar et al., 2003) Western 
Cape (Levitt et al., 2006) and Free State (Mollentze et al., 2006).  The disease is 
common in all population groups.  Figures quoted from the studies were: Indian 
13%, Coloured 11%, Black 5-8% and White 4-5%, respectively.  An increasing 
westernised life-style, urbanisation and ageing may result in a 160-200% 
increase in the total prevalence of this disease by 2030, (Hough, 2007).  Earlier 
predictions by Levitt and Bradshaw (2006) that the impact of the HIV/AIDS 
epidemic may decrease the prevalence of Type II diabetes in South Africa can 
possibly be explained by the early deaths of HIV positive cases     
 
 Studies by Erasmus et al., (1999) assessed glycaemic control in stable Type II 
black South African diabetics attending a peri-urban clinic.  The study showed 
that glycaemic control was poor in the majority of patients, irrespective of sex, 
treatment or duration of diabetes.  The findings of this study agreed with the 
results of Weatherspoon (1994). The results were also supported by some race-
based studies that found glycaemic control to be poorer in the black population. 
Eberhardt (1990) revealed that black women had high HbA1c levels, indicating   
that gender may play a significant role in poor glycaemic control. The poor 
control of blood glucose levels both at the beginning of the study and after 
attendance at the diabetic clinic may reflect the following: 1) insufficient 
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motivation, 2) lack of knowledge, 3) incorrect beliefs about diabetes, and 4) 
particular cultural values.  These factors are all recognized as potential barriers 
to improving diabetic care for blacks, (Erasmus et al., 1999).  
 
 
2.4  Diagnostic Parameters of Diabetes Mellitus 
   
 In 1998, the World Health Organization adopted the diagnostic parameters for 
diabetes established by the American Diabetes Association, (American Diabetes 
association, 1997; Alberti & Zimmet, 1998; American Diabetes Association, 
2005).  Currently there are 3 methods of diagnosing Diabetes Mellitus (American 
Diabetes Association, 2005): 
  
1) Symptoms of diabetes plus casual plasma glucose concentration 
≥200mg/dl (≥11.1 mmol/l).  ‗Casual‘ is defined as any time of the day 
without regard to time since the last meal.   
2)  Fasting plasma glucose ≥126 mg/dl (≥7.0mmol/l).  Fasting is defined as 
no caloric intake for at least 8h; 
3) 2-h post-load glucose ≥ 200mg/dl (≥11.1 mmol/l) during an oral glucose 
tolerance test.  The test should be performed as described by the WHO, 
using a glucose load containing the equivalent of 75g anhydrous glucose 
dissolved in water. 
  
  Any one of the methods listed above is necessary to accompany a single 
random laboratory test and is required to be performed on a different day.  
Impaired glucose tolerance can be diagnosed by an oral glucose tolerance test; 
and occurs when the 2-h post-load plasma glucose concentration is ≥140 mg/dl 
but ≤199 mg/dl (between 7.8 and 11.1 mmol/l).  Impaired fasting glucose is 
diagnosed after a fasting plasma glucose test and is defined by plasma glucose 
levels of ≥100mg/dl but ≤125 mg/dl (between 5.6 and 6.9 mmol/l).  
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 The haemoglobin A1c test is used to monitor the overall glycaemic control in 
people known to have diabetes.  It is not recommended for diagnosis because 
there is not a ‗gold standard‘ assay for haemoglobin A1c and because many 
countries do not have ready access to the test, (Mealey & Ocampo, 2007).   
 
 
2.5 Glycated Haemoglobin (haemoglobin A1c) 
  
 Numerous proteins in the body are capable of being glycated.  
Glycohaemoglobin is formed continuously in erythrocytes as a product of the 
non-enzymatic reaction between the haemoglobin protein, the function of which 
is to carry oxygen molecules, and glucose.  The binding of glucose to 
haemoglobin is stable and haemoglobin remains glycated for the life span of the 
erythrocyte, (Virtue et al, 2004; Mealey & Ocampo, 2007).  Glycohaemoglobin 
levels estimate the average blood glucose level. Over time, higher haemoglobin 
A1c levels reflect higher average blood glucose levels, (Rohlfing, 2002).  
Measurement of haemoglobin A1c is of major clinical value and accurately 
reflects the mean blood glucose concentration over the preceding 1-3 months.  
Haemoglobin A1c levels correlate well with the development of diabetic 
complications, and may become established as a test for the diagnosis and 
progression of diabetes, (Davidson et al., 2000). 
 
 It is generally recommended by the American Diabetes Association, (American 
Diabetes association, 1997; Alberti & Zimmet, 1998; American Diabetes 
Association, 2005), that the haemoglobin A1c test is performed at least twice a 
year in affected people meeting treatment goals.  Affected individuals who have 
not met their treatment goals or had changes to their therapy would benefit from 
a test every three months.  The recommended haemoglobin A1c target value for 
people with diabetes is <7% (non-diabetic persons is <6%), (American Diabetes 
association, 1997; Alberti & Zimmet, 1998; American Diabetes Association, 
2005).  It would appear that achieving this goal is difficult.  A recent population 
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study showed that only 36% of people with Type II diabetes achieved a target 
haemoglobin A1c of <7%, (Koro et al., 2004).  Estimates of HbA1c may be 
reduced in individuals suffering from anaemia or during pregnancy (Manfredi et 
al., 2004).   
 
 
2.6 Aetiology of Periodontal Disease  
 
 Periodontal disease is a microbe-induced chronic inflammatory condition that 
leads to gingival inflammation, periodontal tissue destruction, and alveolar bone 
loss, (Nassar, 2007).  The condition is characterized by destruction of the 
periodontal tissues and results in the loss of connective tissue attachment, loss 
of alveolar bone, and the formation of pathological pockets around the diseased 
teeth. There is no particular age at which it occurs (Flemming, 1999).  Chronic 
periodontitis can  be considered a disease of the middle age, the majority of 
patients first presenting between the ages of 40 to 50.  Periodontal disease has 
been found world-wide and affects all population groups.  It is responsible for a 
substantial proportion of the tooth loss in adulthood (Loe, 1967; Ramfjord, 1967 
Machtei, 1992 and Milward & Chapple, 2003).  Periodontal diseases cannot be 
classified according to their aetiology because they are complex diseases that 
are polymicrobial and polyimmuno-inflammatory in nature.  Thus, periodontal 
disease is the outcome of complex, unpredictable interactions between microbial 
complexes and the host's inflammatory/immune response.  Periodontal disease 
is primarily caused by the accumulation of plaque, i.e. microorganisms, with the 
establishment of and persistent role of other factors.  
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2.7 Risk Factors of Periodontal Disease 
 
 There are several risk factors predisposed to periodontal disease.  The clinical 
assessment of patients with periodontal disease must include an evaluation of 
risk and susceptibility.  While removal of bacterial plaque and plaque retentive 
factors remains the focus of treatment, the successful, long-term management of 
periodontal diseases needs to include the removal and/or control of known risk 
factors (Irwin et al., 2007).   
 
 Risk factors may be modifiable or non-modifiable.  Modifiable risk factors 
are usually environmental or behavioural in nature, whereas non-modifiable 
risk factors are usually intrinsic to the individual and therefore not easily 
changed.  These risk factors have been identified by longitudinal cohort studies 
or controlled clinical trials which identify a causal relationship and can provide 
evidence of the benefit of eliminating the risk factor, respectively, (Van Dyke & 
Dave, 2005).     
 
 
2.7.1 Modifiable Risk Factors for Periodontal Disease 
 
1. Tobacco Smoking is a well-established risk factor for periodontitis.  A direct 
relationship between smoking and the prevalence of periodontal disease has 
been demonstrated in numerous studies, (Kibayashi & Tanaka, 2007; Irwin et al., 
2007).  This association is independent of other factors such as oral hygiene or 
age, (Ismail, Burt & Eklund, 1983).  Cross sectional and longitudinal data show  
that the risk of developing periodontal disease increases with increased smoking, 
(Van Dyke & Dave, 2005).  Cross sectional and longitudinal studies have shown 
that former smokers (clinically defined as two or more years since quitting 
smoking) experience less attachment loss than current smokers but more than 
never-smokers.  Also, the likelihood of developing increasing periodontal disease 
is dose dependent, (Tomar & Asma, 2000). 
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 A number of studies have established that smoking is associated with reduced 
gingival bleeding (Bergstrom & Bostrom, 2001; Muller et al., 2001).  This 
occurrence may reflect an alteration of the calibre of blood vessels perfusing the 
gingival tissues (Mirbod et al., 2001). Reduced bleeding may be the result of a 
disruption of the immune response which in turn may account for the increased 
loss of clinical attachment and alveolar bone.  The use of gingival bleeding as an 
indicator of gingival inflammation therefore is not a reliable indicator of a 
smoker‘s periodontal health.  
  
2. Diabetes is a modifiable risk factor as there is no cure.  However, it can be 
controlled.  Epidemiological studies have demonstrated on numerous occasions 
that the prevalence and severity of periodontitis is significantly higher in patients 
with Type I and Type II diabetes than in those without diabetes and that the level 
of diabetic control is important, (Mealey & Oates, 2006; Van Dyke & Dave, 2005; 
Saremi et al., 2005; Taylor et al., 1996; Emrich, Shlossmann & Genco, 1991). 
 
3. Microorganisms and periodontal disease.  Bacterial plaque at the gingival 
margin results in the development of gingivitis, a condition that is reversible with 
the implementation of oral hygiene measures.  Of all the various microorganisms 
that colonize the mouth, there are three, known as ‗Red Complex‟: 
(i) Porphyromonas gingivalis, 
(ii) Treponema denticola, and  
(iii)Tannerella forsythia (formerly Bacteroides forsythia)  
that have been implicated as aetiological agents in periodontitis, relating 
strikingly to clinical measures of periodontal disease, particularly pocket depth 
and bleeding on probing (Socransky et al., 1998).  
 
 Bacterial species exist in complexes in subgingival plaque.  The purpose of an 
investigation by Socransky et al., (1998) was to define the bacterial complexes 
using data from large numbers of plaque samples and different clustering and 
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ordination techniques.  Subgingival plaque samples were taken from the mesial 
aspect of each tooth in 185 subjects; 160 with periodontitis and 25 without 
periodontitis. 5 major complexes were consistently observed using any of the 
analytical methods.  
  
(1) Red Complex consisting of the tightly related group: 
(See list above) 
 
(2) Orange Complex consisting of a tightly related core group,  
(i) F. nucleatum 
(ii) Prevotella intermedia 
(iii) Prevotella nigrescens, and 
(iv) Peptostretococcus micros. 
Species associated with this group included: Eubacterium nodatum, 
Campylobacter rectus, Campylobacter showae, Streptococcus constellatus, 
and Campylobacter gracilis.   
 
(3) Green Complex consisting of the 3 Capnocytophaga species: 
(i) Campylobacter concisus 
(ii) Eikenella corrodens, and  
(iii)Actinobacillus Aggregatibacter actinomycetemcomitans. 
 
(4) Yellow Complex consist of a group of streptococci: 
(i) Streptococcus mitis, 
(ii) Streptococcus sanguis, and 
(ii) Streptococcus oralis, were closely related in this group. 
 
(5) Purple Complex 
(i) Actinomyces odontolyticus, and  
(ii) Veillonella parvula. 
 
 
 
 
 
 13 
 Socransky et al., (1998) investigated the relationship of the species in the 
different complexes to pocket depth and bleeding on probing.  All species in the 
‗Red and Orange complexes‘ showed a strong relationship with pocket depth, 
showing an increase in prevalence and numbers with increasing pocket depth.  
The relationship was found to more significant with the ‗Red Complex‘.  Also the 
red complex and the individual species in that group were also strongly 
associated with bleeding on probing.      
 
 The presence of periodontal pathogens is not sufficient to cause disease.     
The chance of developing periodontal disease in an individual who harbours one 
of the putative periodontal pathogens is not high enough to consider them a risk 
factor (Ezzo and Cutler, 2003).  Therefore the presence of these microorganisms 
may be risk indicators of periodontal disease, but other factors need to be 
present; anatomic factors such as furcations, root concavities, developmental 
grooves, restorative margin overhangs etc. which all harbour bacterial plaque 
and make these areas difficult for the clinician to instrument, (Van Dyke and 
Dave, 2005).    
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2.7.2 Non-modifiable Risk Factors for Periodontal Disease 
 
1. Genetic Factors 
 Although bacterial infection is the etiologic agent in periodontal disease, 
studies of identical twins suggest 50% of susceptibility to periodontal disease is 
due to host factors, (Michalowicz et al., 2000).  Similarly, indigenous and 
relatively isolated populations have been shown to develop distinct periodontal 
disease presentations that differ from group to group, (Ronderos et al., 2001).  
2. Host response 
 There is evidence to suggest that tissue destruction occurring in periodontal 
disease results from an improper immune response to bacteria rather than 
directly to the destructive effects of the bacterial pathogens, (Van Dyke and 
Serhan, 2003).  In localized aggressive periodontitis, overly active or ―primed‖ 
neutrophils may be responsible for mediating tissue destruction, (Van Dyke and 
Serhan, 2003).  Interleukin-1 (IL-1) gene polymorphisms have been linked to 
periodontal disease by Guzman et al., (2003).  The authors have demonstrated a 
possible relationship between IL-1 genotype and periodontal status in diabetics.  
To date no definitive IL-1 genotype that places individuals in any given population 
at risk for periodontal disease.  Furthermore, the evidence suggesting possible 
interactions between IL-1, smoking and diabetes suggest that there is interplay 
between genetic an environmental factors that results in periodontal disease, 
(Van Dyke and Dave, 2005). 
3. Osteoporosis  
 Osteoporosis has been suggested as another risk factor for periodontitis.  
Several studies have shown that alveolar bone density is altered in osteoporitic 
individuals.  Lerner, (2006), stated that in females with postmenopausal 
osteoporosis, the possibility exists that a lack of oestrogen influences the activity 
of bone cells and immune cells by enhancing the progression of alveolar bone 
loss.  Fewer studies have demonstrated a relationship with clinical attachment 
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levels.  However, these results have been contraindicated by several other 
studies.  Phipps et al., (2007), evaluated the association between periodontal 
disease and bone mineral density (BMD) in a cohort of 1347 older men, who 
were recruited from the ‗Osteoporotic Fractures in Men Study.‘  The authors 
found no association between periodontitis and skeletal bone mineral density 
among older men.  
4. Other Systemic Diseases 
 Several deficiencies of neutrophil function have been related to periodontal 
disease.  These include Chediak-Higashi syndrome, cyclic neutropenias, lazy 
leukocyte syndrome, agranulocytosis, leukocyte adhesion deficiency, Downs 
syndrome and Papillon Lefevre syndrome.  Except for Downs syndrome, these 
diseases are very rare, so probable though not definitive relationships to 
periodontal disease have not been established (Deas et al., 2003). 
5. HIV      
 It has been hypothesized that the immune dysfunction associated with human 
immunodeficiency virus (HIV) infection and acquired immunodeficiency 
syndrome (AIDS) increases susceptibility to periodontal disease; characterised 
by necrotizing ulcerative periodontitis.  Aas et al., (2007) compared the 
predominant bacterial and fungal species associated with gingivitis, periodontitis, 
and linear gingival erythema, in HIV positive subjects with different immune 
status.  The classical putative periodontal pathogens of the ‗Red Complex‘, were 
not detected in these subjects while other species, such as Gemella, 
Streptococcus and Candida albicans were evident.  These findings suggest that 
alternative bacterial and fungal species may be involved in the periodontal 
diseases associated with HIV. These are indicative of opportunistic infections in a 
highly susceptible immunocompromised host.   
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2.8 Periodontal Infections and Diabetes Mellitus  
 
 The association between periodontal disease and diabetes has been explored 
in several studies.  Periodontal disease is more prevalent and more severe in 
persons with diabetes than non-diabetic persons. 
 
 Diabetes mellitus type II is a complex metabolic disease characterized by 
chronic hyperglycaemia.  The peripheral resistance to insulin action, impaired 
insulin secretion and increased glucose production in the liver, means there is an 
increase in glucose in the gingival fluid and blood, with similar plaque and 
gingival scores.  This could change the environment of the micro-flora, inducing 
qualitative changes in bacteria that could account for the severity of periodontal 
disease in poorly controlled diabetics.  These patients tend to suffer from a 
greater loss of attachment, increased bleeding on probing, and increased tooth 
mobility, with a retarded healing capacity.  Chronic hyperglycaemia adversely 
affects the synthesis, maturation, and maintenance of collagen and extracellular 
matrix.  Advanced glycation end products (AGEs) are formed in the 
hyperglycaemic state, by numerous proteins and matrix molecules undergoing a 
nonenzymatic glycosylation.  These AGEs crosslink with collagen, making it less 
soluble and less likely to be normally repaired or replaced, therefore rendering 
the periodontal tissues more prone to destruction. This altered collagen 
metabolism, means the healing potential of diabetics is reduced. This coupled 
with the fact that they have an altered polymorphonuclear Leukocyte function, 
therefore leading to further susceptibility to infection, means they are more prone 
to periodontal breakdown, as the diabetic control decreases.   
 
 Studies that have examined the relationship between diabetes and 
periodontitis are heterogeneous in design and aim.  Thus, both positive and 
negative conclusions have been drawn with respect to the relationship between 
the two diseases.  There is no difference in impact between Types I and II 
Diabetes Mellitus, (Van Dyke & Dave, 2005).  Diabetic parameters examined 
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include glycaemic control, duration of the disease, presence of other diabetes 
associated complications and population studied.  Periodontal parameters 
examined have included gingivitis, clinical attachment loss, and alveolar bone 
loss (Tomar and Asma, 2000).  A review of the literature by Mealey and Oates, 
(2006) stated that, ‗Diabetes increases the risk of periodontal diseases, and 
biologically plausible mechanisms have been demonstrated in abundance‘.   The 
impact of periodontal diseases on glycaemic control of diabetes and the 
mechanisms through which this occurs is less clear.  Inflammatory periodontal 
diseases may increase insulin resistance in a similar way to obesity, aggravating 
glycaemic control.  Further research is needed to clarify this aspect of the 
relationship between periodontal diseases and diabetes, (Mealey & Oates, 2006; 
Kinane & Chestnutt, 1997).  Studies have shown a relationship between poor 
glycaemic control and periodontal disease parameters (Navarro-Sanchez et.al., 
2007, Guzman et.al., 2003; Tsai et at., 2002; Cutler et al., 1999).  Navarro-
Sanchez et al. (2007) have suggested a complex two-way relationship between 
Diabetes Mellitus and periodontitis; each disease having a potential impact on 
the other.  The study revealed that clinical and immunological improvements 
were obtained by significantly decreased HbA1c values in Type II diabetic 
subjects.  The authors suggested that larger studies are needed to confirm the 
finding and establish whether periodontal therapy had a significant effect on 
glycaemic control.  Cross- sectional studies on Pima Indians, a group displaying 
the highest prevalence of Type II diabetes in the world, show an odds ratio of 2.8 
to 3.4 for developing periodontal disease in Type II diabetics compared to non-
diabetics (Emrich et al., 1991).  In a prospective longitudinal study of 628 
subjects, (age ≥35 years), Saremi et al., (2005) examined the effect of 
periodontal disease on overall and cardiovascular disease; mortality in Pima 
Indians with Type II diabetes.  Periodontal abnormality was classified as no or 
mild, moderate and severe, based on panoramic radiographs and clinical dental 
examinations.  Based on the results of this study the authors concluded that, 
‗periodontal disease is a strong predictor of mortality from ischaemic heart 
disease and diabetic nephropathy in Pima Indians with Type II diabetes.  The 
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effect of periodontal disease is additional to the effects of traditional risk factors 
for these diseases.  Similarly, longitudinal studies have shown increased risk of 
on-going periodontal destruction in diabetics as compared to non-diabetics with 
an odds ratio of 4.2.  Finally, studies have been done which suggest that poorly 
controlled diabetics respond less successfully to periodontal therapy compared to 
well-controlled and non-diabetics (Navarro- Sanchez et al., 2007; Promsudthi et 
al., 2005; Kiran et al., 2005; Tsai, Hayes and Taylor, 2002).   
 
 Non-surgical periodontal treatment is associated with improved glycaemic 
control in Type II diabetic patients and can be undertaken along with the 
standard measures for the diabetic patient care.  Non-surgical periodontal 
treatment resulted in a significant decrease in HbA1c levels (Garcia, 2007).  
 
 Most of the studies done over the years have been on the relationship 
between periodontal disease and IDDM (Insulin Dependent Diabetes Mellitus).  
There seemed to be only limited information available on the relationship 
between periodontal disease and NIDDM (Non-Insulin Dependent Diabetes 
Mellitus).   
 
 The most extensive studies on the relationship between periodontal status and 
Diabetes Mellitus have been done amongst the Pima Indians from the Gila River 
Indian community in Arizona.  This tribe has the highest prevalence of Type II 
diabetes in the world.  Data from 2,483 non-diabetic and 736 diabetic subjects 
was assessed.  Panoramic radiographs were used to assess interproximal bone 
loss while probing depth and clinical attachment loss were taken with a 
graduated probe (Shlossman et al., 1990). 
 
 In one particular review, of the 'Bidirectional interrelationships between 
diabetes and periodontal diseases', 8 reports were identified limited to subjects 
with Type II diabetes.  Three of these reports included only adults.  The 
remaining 5 reports are from an epidemiological study in the Pima Indians of the 
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Gila River Indian community, Arizona and include subjects ages 5 and older or 
15 and older.  These 8 studies all reported significantly poorer periodontal health 
in subjects with diabetes.  Emrich et al., (1991) and Taylor (2001) reported that 
the odds were approximately 3 times greater for people with diabetes to have 
destructive periodontal disease after controlling other important factors.  Nelson 
et al., (1990) found a 2.6-fold greater risk of advanced periodontal disease 
incidence, and Taylor et al. (1998) reported that subjects with Type II diabetes 
had a 4-fold greater risk for more severe alveolar bone loss progression.  Some 
studies have also reported no association (Ervasti, et al., 1985).  Therefore there 
is still a need to generate more data on diabetes and periodontal disease so that 
the issue of the association of the two diseases becomes clearer.  Some of the 
studies which took the level of glycaemic control into consideration demonstrate 
that poor glycaemic control contributes to a higher prevalence or more severe 
form of the periodontal disease (Almas et al., 2001; Tsai, Hayes & Tailor, 2002).  
A study with insulin dependent diabetics found a correlation between clinical 
attachment loss and duration of diabetes (Firalti, 1997) and another did not find a 
significant relationship between duration of diabetes and periodontal status 
(Bridges, 1996).  Therefore, the need to carry out more studies assessing the 
severity and prevalence of periodontal disease in Type II diabetics, compared to 
poorly controlled Diabetes Mellitus on the basis of glycaemic control is evident. 
 
 One South African study showing the relationship between Type II Diabetics 
and the severity of periodontal disease (Matu,  2009) is reported.  Statistics show 
that 7-8% of the South African population suffers from Diabetes, thus, there is a 
definite need for further research in this area.   
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CHAPTER 3 
 
AIMS AND OBJECTIVES: 
Research Design and Methodology 
 
 
3.1 Introduction 
 
 In this chapter the research design and method used to obtain data are 
presented.  The purpose of this study was to test the hypothesis that the 
prevalence and severity of periodontal disease is greater, for individuals with 
poorly controlled Type II Diabetes Mellitus compared to those with better 
controlled Type II Diabetes Mellitus. 
 
 
3.2 Research questions 
 
 This study will address the following question: 
  
1. What is the prevalence and severity of periodontal disease amongst poorly 
controlled and controlled Type II diabetics, attending Tygerberg Hospital, Cape 
Town? 
 
Aim of the study 
 To determine the prevalence and severity of periodontal disease in poorly 
controlled and better controlled Type II diabetics compared to a control group of 
non-diabetics, at Tygerberg hospital. 
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Objectives 
1. To determine the prevalence and severity of periodontal disease in Type II 
diabetics and its association with glycaemic control. 
 
 
3.3 Null Hypothesis 
 
There is no difference in the prevalence and severity of periodontal disease in 
poorly controlled and better controlled non insulin dependant diabetics Type II. 
 
 
3.4  Study design 
 
 The study will be an observer blind, descriptive cross sectional study.  A 
regression analysis will be undertaken of existing records (18 months).     
 
 
3.5  Study area 
 
 The study was carried out at Tygerberg Hospital, located in the Tygerberg 
area, Cape Town, South Africa.  The hospital is an outpatient facility under The 
Department of Health in the Western Cape. 
 
 
3.6 Study population 
 
The study population consisted of Coloured female patients aged between 30-60 
years, with a medical history of Type II diabetes who attend the Tygerberg 
Hospital. 
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1. Those who had an appointment to see the doctor for review purposes.  The 
review appointments were scheduled according to the level of control. 
2. Those that belong to a "members club".  These had received diet education as 
a way of managing their diabetic status. 
3. Those who came to collect medicine from the hospital pharmacy. 
 
Groups one and two attended the hospital on Mondays and Tuesdays.   
 
 
3.7 Exclusion criteria 
Diabetic patients were excluded from the study if: 
 
1. Three Ramfjord teeth selected for recording or their substitutes were absent. 
2. They were on prophylactic antibiotics or on antibiotic treatment one month 
prior to the examination. 
3. They were pregnant. 
4. They had only been diagnosed and treated as Type II diabetic < 18 months. 
5. Calculus obstructed the cement-enamel junction or sulcus made it difficult to 
record the pocket depth measurement. 
6. Edentulous patients. 
7. They did not belong to the group consisting of coloured female patients aged 
between 30 to 60 years. 
8. Patients who had had NSAIDS for the last 5 days prior to examination.  
9. They suffered from any bleeding disorders or were on anticoagulant therapy, 
e.g. warfarin. 
10. If the assessment of glycaemic control during the past 18 months was not 
possible; if greater than or equal to the last 3 HbA1c values were not 
available, to obtain an average value. 
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11. They were taking anti-epileptic drugs, as these may have caused gingival 
overgrowth. 
 
 
3.8 Sample Size 
 In order to calculate the size of the study a retrospective analysis of patient 
records was carried out.  One hundred randomly selected records were 
assessed so as to ascertain the prevalence of poorly controlled versus controlled 
Type II diabetics i.e. one hundred HbA1c records were categorized according to 
their assay. Recording of HbA1c of >7% was considered to be readings of poorly 
controlled diabetes.  HbA1c recordings of <7% are considered to be better 
controlled diabetics. 
 
 
3.9 Sampling Procedure 
 
 All Type II diabetic patients that were available during each day of 
examination, that consent in writing to the study, met the inclusion criteria and 
had valid HbA1c readings taken in the recent 3 months. 
 
 The clinical examination was done 'Observer Blind', to avoid bias, i.e. the 
clinical researcher didn't know the diabetic status prior to examination. The 
individual‘s HbA1c calibration needed to have been recorded within the last 3 
months.  The information was verified by the dental assistant but the control 
factor was not revealed to the clinical researcher.  The method used to determine 
HbA1c at Tygerberg Hospital was an automated one employing the Advia-1800 
auto analyzer; reported CV= 5-10%. 
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3.10 Calibration 
 
 Prior to carrying out the study, the investigator carried out an exercise to 
become familiar with the various indices to be used. He was calibrated against 
an experienced clinician.  Fourteen patients were examined for plaque, gingival 
health and probing depth. The teeth of each patient was divided so that each 
examiner had an equal number of teeth to evaluate in a random manner.    
 
 The average score for each examiner was calculated per patient.  All the 
above variables were assessed.  The differences in the scores of the two 
examiners were calculated by a statistician using Wilcoxon Signed Rank Sum 
test.  
 
 
3.11 Data Collection 
 
 The faculty manager was requested to inform the staff of Tygerberg medical 
hospital about the study.  These in turn informed the patients.  A trained dental 
assistant recruited patients to the dental examination area.  The dental assistant 
performed a preliminary interview to ascertain whether the individuals met the 
criteria for the study.   When in doubt, an opinion of a medical practitioner was 
sought to confirm the patient's diagnosis by consulting the patient's medical 
records.   
 
Patients were provided with a consent form (appendix I).  They were allowed to 
ask questions and any information they needed to know was clarified verbally. 
Only those  who signed the document in writing were recruited into the study. 
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3.11.1 Dental examination 
 
 In order to remove operator variability in the recording of data, a single 
examiner did examinations,   The patient was seated on a dental chair with 
standard overhead light in a well-ventilated room with good natural light. A 
questionnaire-interview (appendix II) was used to obtain demographic data, 
dental history, medical history and social history. In order to avoid bias, the 
medical history was not revealed to the examiner until completion of scoring for 
periodontal disease. The examiner then counterchecked the information 
recorded in the questionnaire-interview to confirm that it was correct. 
 
3.11.1.1 Scoring for periodontal disease 
 
 Data was captured in a record sheet (Appendix III).  Scoring for periodontal 
disease was done on six "index teeth" as described by Ramfjord, (1967). These 
are: 
i) Maxillary right first molar (16) 
ii) Maxillary left central incisor (21) 
iii) Maxillary left first bicuspid (24) 
iv) Mandibular left first molar (36) 
v) Mandibular right central incisor (41) 
vi) Mandibular right first bicuspid (44) 
 
If the "index tooth" was missing, the tooth immediately distal to it was used, and 
the deepest probing depth was recorded.  If this tooth was also missing, the tooth 
immediately mesial to the ―index tooth‖ was used. If no acceptable substitute was 
found, no information was recorded for that area of the mouth. 
 
The following was scored for: 
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3.11.1.2 Bacterial plaque 
 
 Plaque index (P1I) as described by Loe (1967) (appendix IV) was used to 
score for bacterial plaque.  Scoring was done on mesial, buccal, distal and 
palatal (or lingual) surfaces of "each index" tooth.  A periodontal probe was used 
for checking presence of plaque. The average score of all the sites was 
calculated and taken as the plaque score for the patient.  Percentage of sites 
with each of the four scores (0-3) were calculated. 
 
3.11.1.3 Gingival health 
 
 Scoring for gingival health was done using gingival index (GI) as described by 
Loe (1967) (appendix V).  Gingival index was scored on mesial, buccal, distal 
and palatal along the coronal side of the pocket.  The average score of all the 
sites was calculated and taken as the gingival score for the patient.  Percentage 
of sites with each of the four scores (0-3) was calculated. 
 
3.11.1.4 Calculus 
 
 Absence or presence of calculus was recorded for each "index tooth".  This 
was examined using a dental explorer probe.  The percentage of teeth with 
calculus was calculated for each patient. 
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3.11.1.5 Probing depth 
 
 This was measured with a graduated periodontal probe from the gingival 
margin to the bottom of the gingival pocket on six points of each "index tooth".  
These are midbuccal, midlingual, mesiobuccal, mesiolingual (or mesiopalatal), 
distobuccal and distolingual (or distopalatal).  The average pocket depth of each 
individual was calculated.  The percentage of sites with pocket depths of ≥ 4mm, 
6mm and 8mm was calculated. 
 
3.11.1.6 Clinical recession 
 
 This was measured with a graduated periodontal probe from the 
cementoenamel junction to the bottom of the gingival pocket on six points of 
each "index tooth".  These are midbuccal, midlingual, mesiobuccal, mesiolingual 
(or mesiopalatal), distobuccal and distolingual (or distopalatal).  The average 
clinical attachment loss of each individual was calculated. The percentage of 
sites with clinical attachment loss of ≥ 4mm and above was calculated. 
 
3.11.1.7 Number of teeth 
 
 The number of clinically visible teeth in the mouth was recorded in both the 
poorly controlled diabetics and controlled Type II diabetic control group. 
 
3.11.1.8 Measuring glycaemic control 
 
 To be included in the study the patient was  to have had ≥3 HbA1c calibrations 
recorded in the previous 18 months, and the last recording must have been in the 
last three months.The results were recorded in their medical notes.  These 
details were confirmed by the dental assistant prior to the clinical examination.  
On the basis of this information the individuals were categorized into poorly 
controlled, (with a HbA1c value >7%) or better controlled, (<7%) group.  
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3.12 Data capture and statistical analysis 
 Data analysis was done in consultation with a statistician.  Data was captured 
by means of MS Excel, as well as the basic transformations also in Excel©.  
Statistical analysis was performed using SPSS (Statistical package for social 
sciences version 14.0) and NCSS (Number cruncher statistical system).  Basic 
descriptive statistics were determined for all the measurements within the two 
groups (poorly controlled and better controlled).  Applicable statistical tests were 
performed to compare the two groups.  Statistical tests, significant at the 5% 
level (p ≤ 0.05) were recorded. 
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CHAPTER 4 
 
Ethics 
 
4.1 Ethics Statement: 
 Patients who participated in this study had an oral examination.  They were 
asked questions about their dental and medical health and also some aspects of 
their social habits.  The oral examination was a simple, minimally invasive 
procedure with minimal discomfort. 
 
 Patients who were diagnosed as being affected by  periodontal disease were 
offered a referral to the department of Periodontology at Tygerberg hospital or 
Mitchell‘s Plain oral health centre.  These individuals were placed on a waiting list 
for a periodontal assessment in the undergraduate clinic, or were referred to the   
postgraduate clinic depending on the severity of their disease.  Alternatively, 
individuals were advised of their periodontal status and prompted to seek advice 
and treatment from their local General Dental Practitioner.  
 
 Patient participation in the study was voluntary.  Participation had no harmful 
effects and individuals could withdraw from the study any time they wished. 
 
 The study was approved by the Ethics Committee of the University of the 
Western Cape.  Informed written consent was obtained from all patients and 
controls. 
 
 All patient information obtained from this study remained confidential, as all 
medical in confidence protocols were observed.      
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CHAPTER 5 
 
RESULTS 
 
5.1 Introduction 
 
 The influence of the level of HbA1c on the dental health of diabetic patients 
(Type II) was studied and it was decided to concentrate on female patients so as 
to exclude variables between the genders.  A feature of Type II Diabetics is that 
there is a HbA1c of more than six per cent.  The experimental layout of such a 
study could be planned in two ways; firstly a group of Type II Diabetics could be 
compared to a Control Group (without diabetes).  Secondly, a ―Regression 
Approach‖ could be followed, in which Type II Diabetics and the Controls were 
grouped together.  In the ―Regression Approach‖ the influence of the information 
contained in HbA1c values are better utilised.  
 
 The sample size of the total group to investigate the influence of the level of 
HbA1c on the dental health of diabetic patients by means of the ―Regression 
Approach‖ was decided to be sixty.  
 
 A quarter of the cohort was used as Controls (with HbA1c less than six, as 
these are classified as Non-diabetic controls).  The sample resulted in 47 Type II 
Diabetics and 16 Control female subjects.   
 
Discussion of Results in Chapter 6 
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Table 1 
Descriptive Statistics of the Ages of individuals in the sample as well as a 
comparison of the Median Ages  
  
 
 
 
 
 
 
 
 
 
 
cx
Wilcoxon Rank Sum Test for the Median Ages 
Large Sample Approximation 
Test Statistic Z = 2.1396 
P-Value = 0.0324 
 
 
 Table 1 illustrated that the difference between the two Medians was seven 
years.  The average age of the Non-diabetic Control Group was less.  The 
minimum and maximum of the two groups were comparable.  The age difference 
would therefore not influence the results of the study.  However, the Median ages 
were significantly different only on the 5% level. 
 
 
 
 
 
 
 
 
 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The ages of all subjects 
 were available) 47 16 63 
Average Age 45.0 39.7 43.6 
Median 43.0 36.0 42.0 
Standard Deviation 9.50 8.58 9.49 
Minimum 30 32 30 
Maximum 63 58 63 
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Table 2 
Descriptive Statistics of the Mean HbA1c Values of individuals in the sample as 
well as a comparison of the Median of HbA1c.  (The HbA1c was not measured 
for the Non-diabetics and was assumed to be less than five) 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The HbA1c values of all 
 subjects  were available)  47 16 63 
Average of Mean HbA1c Values 9.63 <5.0 8.45 
Median 9.60 <5.0 8.47 
Standard Deviation 1.96 — 2.64 
Minimum 6.1 — 5 
Maximum 14.07 — 14.07 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 5.9372 
P-Value = 0  
 
 
 Sixteen healthy female volunteers, with at least nine teeth each, were selected 
for the Non-diabetic Control Group.  Due to the sample structure and the 
selection of the participants the two groups differed statistically (p<0.01 the 
assumptions of the Wilcoxon Rank Sum Test is not satisfied in this case, mainly 
because HbA1c was not determined for the Control Group but assumed to be 
less than six).  Professor Hough advised that, to avoid personal complications, it 
must be assumed that the control group‘s HbA1c levels were less than six. 
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Table 3 
Descriptive Statistics of the Number of Teeth of individuals in the sample as well 
as a comparison of the Median of the Number of Teeth 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The number of teeth of all  
subjects  were available) 47 16 63 
Average of number of Teeth 19.98 19.13 19.76 
Median 22.00 21.50 22.00 
Standard Deviation 6.83 5.99 6.59 
Minimum 7 10 7 
Maximum 31 26 31 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 0.5211 
P-Value = 0.6023 
 
 
 From the Averages and Medians of the two sub-groups it could be deduced 
that it was the same for the two sub groups. 
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Table 4 
Descriptive Statistics of the Observed Gingivitis Index of individuals in the sample 
as well as a comparison of the Median of Observed Gingivitis Index 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The Observed Gingivitis  
indexes of all subjects  were available) 47 16 63 
Average of Gingivitis Index 1.56 1.06 1.43 
Median 1.63 1.13 1.54 
Standard Deviation 0.43 0.53 0.50 
Minimum 0.38 0.08 0.08 
Maximum 2.6 1.83 2.6 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 3.087 
P-Value = 0.002 
 
 
 The Medians of the Gingivitis Index of the sub-groups were different (p<0.01) 
and it indicated that the Non-diabetic Control Group had less gingivitis than the 
Diabetic Group. 
 
 
Table 5 
Descriptive Statistics of Observed Plaque Index of individuals in the sample as 
well as a comparison of the Median of Observed Plaque Index 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The Observed Plaque  
Indexes of all subjects  were available) 47 16 63 
Average of Plaque Index 1.45 0.97 1.33 
Median 1.42 0.94 1.25 
Standard Deviation 0.56 0.50 0.58 
Minimum 0.45 0.08 0.08 
Maximum 3 1.67 3 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 2.6844 
P-Value = 0.0073 
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The Medians of the Plaque Index of the sub-groups were different (p<0.01) and it 
indicated that the Non-diabetic Control Group had less plaque than the Diabetic 
Group. 
 
 
 
Table 6 
Descriptive Statistics of Observed Calculus Index of individuals in the sample 
and a comparison of the Median of Observed Calculus Index 
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The Observed Calculus 
 Indexes of all subjects  were available) 47 16 63 
Average of Calculus Index  0.46 0.27 0.41 
Median 0.33 0.33 0.33 
Standard Deviation 0.30 0.21 0.29 
Minimum 0 0 0 
Maximum 1 0.67 1 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 1.9422 
P-Value = 0.0521 
 
 
 The Medians of the Calculus Index of the two sub-groups were less different 
than that of the Gingivitis Index and the Plaque Index but only on the 10% 
significance level.  For the averages the differences were considerable but for the 
medians the estimate was the same.   
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Table 7 
Descriptive Statistics of Observed Mean Pocket Depths of the Maxilla of 
individuals in the sample as well as a comparison of the Median of Mean Pocket 
Depths  
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes  47 16 63 
Count of Observed Maxilla Pocket 
Depths  39* 11* 50 
Average of Maxilla Pocket Depths  3.41 1.91 3.08 
Median 3.11 1.83 2.72 
Standard Deviation 1.27 0.34 1.30 
Minimum 1.9 1.5 1.5 
Maximum 7 2.6 7 
 *8 Missing *5 Missing  
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 4.3092 
P-Value < 0.0001 
 
 
 There were a considerable number of missing values due to the absence of 
teeth in the maxilla‘s of the participants.  Eight subjects had missing values for 
Maxilla Pocket Depths (17% missing) and five subjects had missing values for 
Maxilla Pocket Depths (31% missing) in the Diabetes Mellitus and Non- Diabetes 
Mellitus respectively.  The Medians of the remaining observations were 
significantly different (p<0.0001).   
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Table 8 
Descriptive Statistics of Observed Mean Pocket Depths of Mandibles of 
individuals in the sample as well as a comparison of the Median of Mean Pocket 
Depths  
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The Mandible Pocket  
depths of all subjects  were available) 47 16 63 
Average of Mandible Pocket Depths  2.91 1.93 2.66 
Median 2.78 1.75 2.56 
Standard Deviation 0.71 0.47 0.79 
Minimum 1.50 1.11 1.11 
Maximum 4.33 2.89 4.33 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 4.4766 
P-Value < 0.0001 
 
 
 There were no missing values due to the sufficient presence of teeth in the 
mandibles. The Medians of the observations were highly significantly different 
(p<0.0001).   
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Table 9  
Descriptive Statistics of Observed Mean Recession Values of the Maxilla of 
individuals in the sample as well as a comparison of the Median of Mean 
Recession Values  
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes  47 16 63 
Count of Maxilla Recession Values  39* 11* 50 
Average of Maxilla Recession Values  1.18 0.69 1.07 
Median 1.11 0.67 1.03 
Standard Deviation 0.58 0.40 0.58 
Minimum 0.06 0.28 0.06 
Maximum 2.75 1.56 2.75 
 *8 Missing *5 Missing  
       (Not measured) 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 2.5996 
P-Value = 0.0093 
 
 
 Because many participants did not have maxillary teeth Due to the absence of 
maxillary teeth  of the participants there were a considerable number of missing 
values.  Eight subjects had missing values for Recession of the Maxilla (17% 
missing) and five subjects had missing values for Receding Values (31% 
missing).  The Medians of the remaining observations were significantly different 
(p<0.01).   
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Table 10 
Descriptive Statistics of Observed Mean Recession Values of the Mandibles of 
individuals in the sample as well as a comparison of the Median of Mean 
Receding Values  
 
  Diabetic 
Non-
diabetic Total 
Sample Sizes (The Mandible Recession Values 
of all subjects  were available) 47 16 63 
Average of Mandible Recession Values  1.37 0.88 1.24 
Median 1.28 0.92 1.17 
Standard Deviation 0.68 0.31 0.64 
Minimum 0.39 0.33 0.33 
Maximum 3.44 1.33 3.44 
 
Wilcoxon Rank Sum Test 
Large Sample Approximation 
Test Statistic Z = 2.8344 
P-Value = 0.0046 
 
 
 There were no missing values due to the sufficient presence of teeth in the 
mandibles. The Medians of the observations were highly significantly different 
(p<0.01).   
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5.2 Regression and Correlation Relationships present in the sample  
 
 The statistical methods, Regression and correlation analysis, are the two sides 
of the same coin.  The Pearson Correlation Coefficient varies between –1 and +1 
and regression has high predictability when the correlation is near to –1 and +1. 
When the correlation is positive, the two measurements increase together.  A 
negative correlation indicates that as the one measurement increases, the other 
decreases, an inverse relationship. 
 
 Instead of the Pearson Correlations, Spearman Rank Correlation Coefficients, 
stored in matrices, were used to summarise the relationships between the 
measured variables Age, Mean HbA1c, Number of teeth, Gingivitis Index, Plaque 
Index and Calculus Index.  Spearman Rank Correlations were used because it is 
more dependable in the presence of possible outliers.  
   
Table 11(a) 
Table of Spearman Rank Correlations; each cell contains the correlation, its 
significance value, p value, (whether correlation coefficient was different from 
zero) and the number of data pairs.  Measurement headings are indicated. 
 
Only Diabetics 
   
 
Age 
Mean 
HbA1c 
Number 
of Teeth 
Gingivitis 
Index 
Plaque 
Index 
Calculus 
Index 
Age 1 -0.234 -0.421 -0.0061 0.202 0.306 
 0 0.1138 0.0032 0.9701 0.1731 0.0367 
 47 47 47 47 47 47 
Mean     -0.2345 1 0.073 0.169 0.199 0.025 
HbA1c 0.1138 0 0.6249 0.2548 0.1788 0.8669 
 47 47 47 47 47 47 
Number -0.421 0.073 1 -0.406  -0.552 -0.442 
of Teeth 0.0032 0.6249 0 0.0046 0.0001 0.0019 
 47 47 47 47 47 47 
Gingivitis -0.006 0.169 -0.4062 1 0.8174 0.3893 
Index 0.9701 0.2548 0.0046 0 0.0000 0.0068 
 47 47 47 47 47 47 
 
 
 
 
 41 
Remarks on the matrix in Table 11(a) 
 
1.  No relationship between increasing age and gingivitis index, Spearman Rank 
Correlation (rs = -0.006). 
 
2.  The gingivitis index shows a significant negative correlation with the number 
of teeth, i.e. as the number of teeth increases the gingivitis index decreases. 
 
3.  The gingivitis index shows a significant positive correlation with the calculus 
index, i.e. as the gingivitis index increases the calculus index increases. 
 
4.  Very strong positive relationship between increasing gingivitis and plaque 
index, (rs = 0.817). 
 
5.  The mean HbA1c increases as the age decreases, i.e. a negative correlation. 
However the Spearman Rank Correlation, rs = -0.234.is not significant at the 10% 
(0.1) significance level. 
 
The Spearman Rank Correlations of, ―Number of teeth‖, ―Gingivitis Index‖, 
―Plaque Index‖, ―Calculus Index‖, were small and positive and not significantly 
related to HbA1c.   
 
 
Table 11(b) 
Correlation Matrix of Both Groups- 
Diabetics and Non-diabetics 
   
 
Age 
Mean 
HbA1c 
Number 
of Teeth 
Gingivitis 
Index 
Plaque 
Index 
Calculus 
Index 
Age 1 0.076 -0.470 0.134 0.283 0.284 
 0 0.5542 0.0001 0.2959 0.0245 0.0241 
 63 63 63 63 63 63 
Mean  0.0761 1 0.0942 0.3903 0.3654 0.2065 
HbA1c 0.5542 0 0.4616 0.0016 0.0033 0.1045 
 63 63 63 63 63 63 
Number -0.470 0.094 1 -0.326 -0.453 -0.334 
of Teeth 0.0001 0.4616 0 0.0090 0.0002 0.0075 
 63 63 63 63 63 63 
Gingivitis 0.134 0.390 -0.326 1 0.856 0.483 
 0.2959 0.0016 0.0090 0 0.0000 0.0001 
 63 63 63 63 63 63 
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Remarks on the matrix in Table 11(b) 
 
1.  No significance- there is no relationship between increasing age and HbA1c.   
But due to the combination of the two samples the negative of Table 11(a) 
disappeared. 
2.  No significance- there was no relationship between HbA1c and number of 
teeth. 
3.  There was a positive relationship between mean HbA1c and Gingivitis. 
4.  There was a positive relationship between mean HbA1c and Plaque Index.  
5.  There was a positive relationship between Calculus Index and mean HbA1c, 
but it was not significant. 
 
 
 The start of the correlation matrix (four rows and six columns) was presented 
above.  The correlations with ―Age‖ within the complete group (Sample size equal 
to 63) will be discussed initially because ―Age‖ can be seen as a background 
variable.  There was a strong correlation between “Age” and ―Number of Teeth‖ 
and relationships of lesser importance with ―Plaque Index‖ and ―Calculus Index‖.  
When the correlations in the first row (with ―Age‖) were contrasted to the 
corresponding Spearman Correlations, the reduction in the absolute value of the 
correlation indicated that the relationship weakened in those cases. (See 1) 
  
 
 
 
 
 43 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1 
The relationship between HbA1c and Gingivitis Index with the Spearman Rank 
Correlation indicated in the upper left hand corner and the equation of the fitted 
least squares line indicated in the bottom right hand corner 
 
 A reasonably strong relationship existed between HbA1c and the Gingivitis 
Index.  The linear regression equation fitted, was ‗Gingivitis Index‘ = 0.0809 x 
‗HbA1c‘ + 0.747; the slope of this line was 0.0809, implying that for each unit 
increase in the value of HbA1c the Gingivitis Index increased with 0.0809.   
 
  
Spearman Rank Correlation 
Correlation Coefficient = 0.3846  
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Figure 2 
The relationship between HbA1c and Plaque Index with the Spearman Rank 
Correlation indicated in the upper left hand corner and the equation of the fitted 
least squares line indicated in the bottom right hand corner 
 
 A positive association existed between HbA1c and the Plaque Index and similar 
deductions could be made as in the case of the Gingivitis Index and HbA1c. 
 
 
 
 
 
 
  
Spearman Rank Correlation 
Correlation Coefficient = 0.3589  
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Figure 3 
The relationship between HbA1c and the Calculus Index with the Spearman 
Rank Correlation indicated in the upper left hand corner and the equation of the 
fitted least squares line indicated in the bottom right hand corner 
 
 
 A weak positive relationship was observed between HbA1c and the Calculus 
Index. 
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Table 12 
Table of Spearman Rank Correlations; each cell contains the correlation, its 
significance value, p value, (whether correlation coefficient was different from 
zero) and the number of data pairs.  Measurement headings are indicated. 
 
Correlation Matrix for Both Groups 
 
 Maxilla Pocket Depths 
 
Average 
Pocket 
Depth 
Distal 
Buccal 
Average 
Pocket 
Depth 
Buccal 
Average 
Pocket 
Depth 
Mesial 
Buccal 
Average 
Pocket 
Depth 
Distal 
Palatal 
Average 
Pocket 
Depth 
Palatal 
Average 
Pocket 
Depth 
Mesial 
Palatal 
Age 0.295 0.439 0.311 0.342 0.347 0.301 
 0.0377 0.0014 0.0280 0.0152 0.0135 0.0337 
 50 50 50 50 50 50 
Mean  0.521 0.464 0.469 0.633 0.503 0.545 
HbA1c 0.0001 0.0007 0.0006 0.0000 0.0002 0.0000 
 50 50 50 50 50 50 
Number -0.201 -0.292 -0.219 -0.174 -0.165 -0.234 
of Teeth 0.1616 0.0394 0.1269 0.2270 0.2533 0.1019 
 50 50 50 50 50 50 
Gingivitis 0.736 0.602 0.657 0.665 0.496 0.653 
Index 0.0000 0.0000 0.0000 0.0000 0.0002 0.0000 
 50 50 50 50 50 50 
 
  The correlations with ―Age‖ within the incomplete group (50 data pairs 
remaining, 13 contained missing values), will be discussed at the outset because 
―Age‖ can be seen as a background variable.  There was a strong correlation 
between “Age” and ―Average Pocket Depth Top Buccal‖ and relationships of 
lesser extent with {―Average Pocket Depth Top D Buccal‖; ―Average Pocket 
Depth Top M Buccal‖; ―Average Pocket Depth Top D Palatal‖; ―Average Pocket 
Depth Top Palatal‖; ―Average Pocket Depth Top M Palatal‖}.   
 
 The aim of this study was to investigate the possible relationship between 
―HbA1c‖ and periodontal parameters.  The measurement ―HbA1c‖ was strongly 
related with {―Average Pocket Depth Top D Buccal‖; ―Average Pocket Depth Top 
Buccal‖; ―Average Pocket Depth Top M Buccal‖; ―Average Pocket Depth Top D 
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Palatal‖; ―Average Pocket Depth Top Palatal‖; ―Average Pocket Depth Top M 
Palatal‖}.  The scatter plot of ―Average Pocket Depth Top D Palatal‖ and ―HbA1c‖ 
is given below (the Spearman Rank Correlation of this pair of measurements was 
the maximum in the list of six correlations). 
 
 Ignoring the Control Group caused a drop in the significance of the correlations, 
because the number of data pairs was reduced from 50 to 39.  The slopes of the 
regressions of ―HbA1c‖, however, stayed positive. 
 
 
 
 
Figure 4 
Scatter Diagram of ―Average Pocket Depth Top D Palatal‖ and ―HbA1c‖ 
 
 
 The presence of heteroscedasticity in the relationship between ―Average Pocket 
Depth Top D Palatal‖ and ―HbA1c‖ could clearly be observed in that the 
dispersion of ―Average Pocket Depth Top D Palatal‖ for the lower values of 
―HbA1c‖ is less than the dispersion of it at the higher values of ―HbA1c‖ e g 12.     
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Table 13 
Table of Spearman Rank Correlations.  Each cell contains the correlation, its 
significance value (whether correlation coefficient was different from zero) and 
the number of data pairs.  Measurement headings are indicated 
 
Correlation for Both Groups 
 
 Mandible Pocket Depths 
 
Average 
Pocket 
Distal  
Buccal 
Average 
Pocket 
Depth  
Buccal 
Average 
Pocket 
Depth  
Mesial 
Buccal 
Average 
Pocket 
Depth  
Distal 
Lingual 
Average 
Pocket 
Depth  
Lingual 
Average 
Pocket 
Depth  
Mesial 
Lingual 
Age 0.279 0.169 0.379 0.380 0.258 0.355 
 0.0266 0.1858 0.0022 0.0021 0.0415 0.0043 
 63 63 63 63 63 63 
Mean  0.503 0.367 0.572 0.510 0.372 0.505 
HbA1c 0.0000 0.0031 0.0000 0.0000 0.0027 0.0000 
 63 63 63 63 63 63 
Number -0.166 -0.131 -0.131 -0.113 -0.177 -0.198 
of Teeth 0.1948 0.3043 0.3069 0.3799 0.1660 0.1204 
 63 63 63 63 63 63 
Gingivitis 0.634 0.515 0.618 0.568 0.485 0.591 
Index 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 
 63 63 63 63 63 63 
 
 
 A similar pattern existed for the correlation coefficients for the 
―Bottom(Mandibular) Pocket Depths‖ compared to the ―Top (Maxilla) Pocket 
Depths‖ except that the ―Maxilla Pocket Depths‖ were calculated on fewer 
observations due to the higher number of missing values. The gingivitis index 
had a strong positive correlation to the ―Pocket Depth measurements‖.  
Interestingly, there was evidence of weak negative correlations between the 
number of teeth and the ―Pocket Depth measurements‖ implying that, the smaller 
the number of teeth, the greater the ―Pocket Depth measurements‖.  
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Table 14  
Table of Spearman Rank Correlations.  Each cell contains the correlation, its 
significance value (whether correlation coefficient was different from zero) and 
the number of data pairs.  Measurement headings are indicated 
 
Correlation for Both Groups 
 
 Maxilla Recession Distance 
  
Average 
Receding    
Distal  
Buccal 
Average 
Receding     
Buccal 
Average 
Receding    
Mesial  
Buccal 
Average 
Receding    
Distal 
Palatal 
Average 
Receding    
Palatal 
Average 
Receding    
Mesial 
Palatal 
Age 0.437 0.321 0.468 0.502 0.393 0.523 
  0.0015 0.0228 0.0006 0.0002 0.0047 0.0001 
  50 50 50 50 50 50 
Mean  0.347 0.162 0.326 0.424 0.310 0.411 
HbA1c 0.0135 0.2621 0.0208 0.0022 0.0284 0.0030 
  50 50 50 50 50 50 
Number -0.497 -0.488 -0.492 -0.454 -0.349 -0.380 
of Teeth 0.0002 0.0003 0.0003 0.0009 0.0129 0.0065 
  50 50 50 50 50 50 
Gingivitis 0.308 0.369 0.328 0.451 0.407 0.405 
Index 0.0297 0.0083 0.0199 0.0010 0.0034 0.0035 
  50 50 50 50 50 50 
 
 
 The number of observed pairs for the Maxillae (Table 14) was less than that of 
the Mandibles (Table 13) and the number of missing values corresponded 
exactly with that of the ―Pocket Depths‖ of the Maxillae (Table 12).  The ―HbA1c‖ 
correlated reasonably well with {―Average Receding Top D Buccal‖; ―Average 
Receding Top Buccal‖; ―Average Receding Top M Buccal‖; ―Average Receding 
Top D Palatal‖; ―Average Receding Top Palatal‖; ―Average Receding Top M 
Palatal‖}.  Some of the correlations between ―Gingivitis Index‖ and ―Recession 
Distances‖ in Table 14 were significantly different from zero.  There were much 
stronger negative correlations between the number of teeth and the ―Recession 
Distances‖ implying that, the smaller the ―Number of teeth‖, the greater the 
―Recession Distances‖. 
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Table 15 
Table of Spearman Rank Correlations and each cell contains the correlation, its 
significance value (whether correlation coefficient was different from zero) and 
the number of data pairs.  Measurement headings are indicated 
 
Correlation matrix for Both Groups 
  
 Mandible Receding Distance 
  
Average 
Receding 
Distal  
Buccal 
Average 
Receding   
Buccal 
Average 
Receding  
Mesial  
Buccal 
Average 
Receding 
Distal 
Lingual 
Average 
Receding  
Lingual 
Average 
Receding 
Mesial 
Lingual 
Age 0.514 0.351 0.512 0.569 0.407 0.514 
  0.0000 0.0048 0.0000 0.0000 0.0009 0.0000 
  63 63 63 63 63 63 
Mean  0.243 0.192 0.256 0.233 0.300 0.242 
HbA1c 0.0547 0.1325 0.0425 0.0657 0.0169 0.0556 
  63 63 63 63 63 63 
Number -0.511 -0.560 -0.489 -0.553 -0.482 -0.538 
of Teeth 0.0000 0.0000 0.0000 0.0000 0.0001 0.0000 
  63 63 63 63 63 63 
Gingivitis 0.321 0.412 0.362 0.408 0.506 0.403 
Index 0.0104 0.0008 0.0036 0.0009 0.0000 0.0010 
  63 63 63 63 63 63 
 
 
 A similar correlation pattern existed for the ―Average Receding Bottom: Buccal 
& Lingual‖ compared to the ―Average Receding Top: Buccal & Lingual‖ with 
respect to ―HbA1c‖, but the correlations were even weaker than that of the 
Maxillae.   
 
 It could be justified that the regression approach (correlation) be applied to the 
complete sample of 63 individuals.  Most of these correlation coefficients were 
positive and significantly different from zero indicating that ―HbA1c‖ had a 
detrimental influence on the dental measurements.  This link could be indirect in 
that some other properties of diabetes, and not necessarily ―HbA1c‖, affected the 
dental health of diabetics adversely.  
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CHAPTER 6 
 
DISCUSSION 
 
6.1 Analysis and interpretation of results  
In this study, Type II diabetics had significantly higher gingival index (GI), 
plaque index (PI), calculus index (CI) and probing depth (PD). 
 
There were obvious difficulties in obtaining the patient numbers due to the 
high proportion of edentulous individuals attending the diabetes clinic.   A 
regressional approach was therefore used to test the Null hypothesis.  The 
results were conclusive in that the percentage of sites with high GI, PI, CI and 
PD was higher in diabetics than non-diabetics.  The regression analysis 
showed that as the HbA1c increased so did the GI, PI, CI and PD. 
 
Therefore, the Null Hypothesis was disproved as this means that in this 
study diabetics suffered from more severe and had a higher prevalence of 
periodontal disease than non-diabetics.   
 
Many studies have reported a positive correlation between the prevalence 
and severity of periodontal disease and Diabetes Mellitus . This study 
confirms the results from previous cross-sectional studies, that Type II 
diabetics have a higher percentage of gingival sites with deeper probing 
depths than non-diabetics (Bridges, et al., 1996 and Persson, et al., 2003).  In 
contrast, Tervonen and Knuuttila, (1986) found no difference in percentage of 
gingival sites involved between diabetics and non-diabetics. 
 
This study showed that there was a difference in GI, PI, CI and PD 
between Type II diabetics and non-diabetics.  In addition, it illustrated a 
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correlation between HbA1c, PI, CI and   PD.  These results concur with 
studies by Taylor, et al., (1996); Tervonen and Knuuttila, (1986); Taylor, 
(1998); Taylor, Burt, Becker, et al. (1998); Tsai, Hayes and Taylor, (2002).  
Whilst in contrast Bridges et al. (1996) reported no difference.  These 
differences might be due to real differences or reasons coming from statistical 
summary measures for example sample size or outliers. 
 
The use of a control group in this study served as a standard by which the 
severity and prevalence of periodontal disease in the diabetic group could be 
measured and compared.  The nature of the study was cross-sectional, and 
does not enable one to conclude a causal relationship between diabetes 
mellitus and periodontal disease.  HbA1c provided a reliable way of assessing 
glycaemic control in the diabetic group, as described by Kilpatrick et al. 
(1994).  Other studies have used other variables such as fasting blood 
plasma glucose, (Tsai, Hayes and Taylor, 2002; and random blood sugar, 
Almas et al., 2001). 
 
 The critical level for categorising people into well controlled or poorly 
controlled has been arbitrarily set at different levels in different studies, for 
example Taylor, et al. (1998), used HbA1c <9% for better controlled and ≥ 9% 
for poorly controlled.  In order to avoid misclassifying individuals, it was 
decided to use the regression approach instead, where the influence of the 
HbA1c values on the periodontal measurements are better utilised.  For 
applying the regression approach the data on HbA1c had enough dispersion 
to make valid inferences. 
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6.2 LIMITATIONS 
There are some important limitations to the present study: 
 
 Partial mouth recordings protocol was used for the estimation of periodontal 
diseases which may be accurate and efficient in estimating the mean periodontal 
measures but could severely under- and/or over-estimate the prevalence of 
periodontal disease.  This effect would not be significant in this study because it 
was applied to both controls and the diabetic group.  So, if underestimation 
occurred in one group, it was compensated for in the other group. 
 
 The sample size was not large enough to represent the Type II diabetes 
population. 
 
 Other risk factors including smoking, lipid abnormalities, renal impairment, and 
even osteoporosis which not infrequently attend the diabetic state may account 
for periodontal disease independent of Type II Diabetes Mellitus; but these risk 
factors were not considered when doing the statistical analysis. 
 
 
6.3 RECOMMENDATIONS 
It is recommended that an association between Diabetes Mellitus and 
Periodontal Disease must be investigated through large, prospective randomized 
clinical studies, as well as interventional studies.  The preliminary findings 
deduced form this study must be interpreted with caution due to study limitations. 
   
 Multi-centre studies with larger groups of Type II Diabetic populations could 
contribute favourable to more conclusive results. 
 
 Ramfjord (1967) index teeth or their substitutes were used for scoring the 
various parameters of periodontal disease.  This method of recording is very 
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useful in large epidemiological studies, but may have underestimated disease 
prevalence in some individuals in this small study.   To compensate for this 
possible bias, these teeth were used in both the diabetic and control group.  
Ideally, periodontal examination should be performed using a full mouth, 
recording protocol to establish the effect of glycaemic control on periodontitis 
more accurately.   
 
 As part of their regular medical regimen it would be advisable to educate 
diabetic sufferers that they are more likely to be affected by severe Periodontal 
Disease. The importance of controlling their glycaemic levels need to be strongly 
emphasized. 
 
 Both diabetics and non-diabetics in this population should be educated and 
encouraged to attend more regular dental health checks and have their dental 
health managed by alternative treatment methods other than just extractions. 
 
  Health educators should be aware and advise diabetics that periodontal 
disease is a complication of their diabetic state and they should be encouraged 
to maintain their dental health in the optimum condition.  
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CHAPTER 7 
 
CONCLUSIONS 
 
This study was conducted to investigate whether the prevalence and severity of 
periodontitis is more prevalent in poorly controlled Type II diabetic patients, and 
increases on a regressive basis. 
 
The results of the study suggested that there is a higher prevalence of 
periodontal disease in poorly controlled Type II diabetic patients.  
It could be justified that the regression approach (correlation) be applied to the 
complete sample of 63 individuals.  Most of these correlation coefficients were 
positive and significantly different from zero indicating that ―HbA1c‖ had a 
detrimental influence on the periodontal measurements.  This link could be 
indirect in that some other properties of diabetes, and not necessarily ―HbA1c‖, 
affected the periodontal health of diabetics adversely. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 56 
REFERENCES 
 
Aas JA, Barbuto SM & Alpagot T. (2007).  Subgingival plaque microbiota in HIV 
positive patients.  Journal of Clinical Periodontology, 34(3), 189-95.  
 
Alberti KG & Zimmet PZ. (1998).  Definition, diagnosis and classification of 
diabetes mellitus and its complications.  Part 1:  Diagnosis and classification of 
diabetes mellitus provisional report of a WHO consultation.  Diabetic Medicine, 
15, 539-553. 
 
Almas K, Al-Qahtani M, Al-Yami M & Khan N. (2001).  The relationship between 
periodontal disease and blood glucose levels in Type II diabetic patients. Journal 
of Contemporary Dental Practice, 2 (4), 19-24. 
 
American Academy of Periodontology.  (2000).  Diabetes and periodontal 
diseases (position paper).  Journal of Periodontology, 71, 664-678.   
 
American Diabetes Association.  (2005).  Diagnosis and classification of diabetes 
mellitus.  Position statement.  Diabetes care, 29 (Suppl. 1), S37-S42. 
 
American Diabetes Association Expert Committee on the Diagnosis and 
Classification of Diabetes Mellitus. Committee Report.  (1997).  Diabetes Care, 
20, 1183-1197.   
 
Armitage GC. (2004).  Periodontal diagnoses and classification of periodontal 
diseases. Periodontology 2000, 34, 9-21. 
 
Baelum V, Fejerskov O & Karring T. (1986).  Oral hygiene, gingivitis and 
periodontal breakdown in adult Tanzanians.  Journal of Periodontal Research, 
21, 221-232. 
 
 
 
 
 
 57 
Bergstrom J & Bostrom L. (2001).  Tobacco smoking and periodontal 
haemorrhagic responsiveness.  Journal of Clinical Periodontology, 28, 680-685. 
 
Bridges RB, Anderson JW, Saxe SR & Gregory K. (1996).  Periodontal status of 
diabetic and non-diabetic men: Effects of smoking, glycaemic control and socio-
economic factors.  Journal of Periodontology, 67, 1185-1192. 
 
Brown LJ & Loe H. (1993).  Prevalence, extent, severity and progression of 
periodontal disease.  Periodontology 2000, 2, 57-71. 
 
Burt BA.  (1996).  Position paper: epidemiology of periodontal diseases.  
American Academy of Periodontology.  Journal of Periodontology, 67,935-945. 
 
Campus G, Salem A, Uzzau S, Baldoni E & Tonolo G. (2005).  Diabetes and 
periodontal disease: a case control study. Journal of Periodontology, 76, 418-
425.  
 
Centers for Disease Control and Prevention. (2005)  National Diabetes Fact 
Sheet.  Available at: http://www.cdc.gov/diabetes/pubs/estimates.htm. 
 
Cutler CW, Machen RL, Jorwani R & Iacopino AM. (1999).  Heightened gingival 
inflammation and attachment loss in Type II diabetics with hyperlipidemia.  
Journal of Clinical Periodontology, 70, 1313-1321.  
 
Davidson MB, Schriger DL, Peters AL & Lorber B. (2000).  Glycosylated 
haemoglobin as a diagnostic test for Type II diabetes mellitus.  Journal of 
American Medical Association, 283, 606-607.  
 
Deas DE, Mackey SA & McDonnell HT. (2003).  Systemic disease and 
periodontitis: manifestations of neutrophil dysfunction.  Periodontology 2000, 32, 
82-104. 
 
 
 
 
 
 58 
DeFronzo RA & Ferrannini E. (1991).  Insulin resistance.  A multifaceted 
syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and 
atherosclerotic cardiovascular disease.  Diabetes Care, 14, 173-194. 
 
Eberhardt MS, Lackland DT, Wheeler FC & Teutsch SM. (1990).  Glycaemic 
control in blacks and whites with diabetes in two South Carolina communities.  
Diabetes, 39 (suppl 1). 205A.  
 
Emrich LJ, Shlossman M & Genco RJ. (1991).  Periodontal Disease in Non-
Insulin-Dependent Diabetes Mellitus.  Journal of Periodontology, 123-131. 
 
Erasmus RT, Blanco Blanco E, Okesina AB, Gqweta Z & Matsha T.  (1999).  
Assessment of glycaemic control in stable Type II black South African diabetics 
attending a peri-urban clinic.  Postgraduate Medical Journal, 75, 603-606.  
 
Ervasti, T, Knuuttila M, Pohjamo L & Haukipuro K.(1985).  Relationship between 
control of diabetes and gingival bleeding.  Journal of Periodontology, 56 (3), 154-
157. 
 
Ezzo PJ & Cutler CW. (2003).  Microorganisms as risk indicators for periodontal 
disease.  Periodontology 2000, 32, 24-35. 
 
Faria-Almeida R, Navarro A & Bascones A. (2006).  Clinical and metabolic 
changes after conventional treatment of Type II diabetic patients with chronic 
periodontitis.  Journal of Periodontology, 77(4), 591-598.   
 
Flemming TF. (1999).  Periodontitis.  Ann Periodontology, 4, 32-38. 
 
Firalti, E. (1997).  The relationship between clinical periodontal status and insulin 
dependant diabetes mellitus.  Results after 5 years.  Journal of Periodontology, 
68, 136-140. 
 
 
 
 
 
 59 
Fox CH, Jette AM, McGuire SM, Feldman HA & Douglass CW. (1994).  
Periodontal disease among New England elders.  Journal of Periodontology, 65, 
676-684. 
 
Garcia R. (2007).  Periodontal treatment associated with improved glycaemic 
control in Type II diabetic patients.  Evidence-Based Dentistry, 8 (1), 13.  
 
Geerts SO, Legrand V, Charpentier J, Albert A & Rompen EH. (2004).  Further 
evidence of the association between periodontal conditions and coronary artery 
disease.  Journal of Periodontology, 75(9), 1274-1280. 
 
Genco RJ & Loe H. (1993).  The role of systemic conditions and disorders in 
periodontal disease.  Periodontology 2000, 2, 98-116. 
 
Genco RJ, Grossi SG, Ho A, Nishimura F & Murayama Y. (2005).  A proposed 
model linking inflammation to obesity, diabetes, and periodontal infections.  
Journal of Periodontology, 76, 2075-2084.   
 
Guzman S, Karima M, Wang HY & Van Dyke TE. (2003).  Association between 
Interleukin-1 genotype and periodontal disease in a diabetic population.  Journal 
of Periodontology, 74, 1183-1190. 
 
Hough FS. (2007).  Type II diabetes and the metabolic syndrome. Review article.  
 
International Workshop for the Classification of Periodontal Diseases. (1999).  
Annals of Periodontology, 4, 1-108.  
 
Irwin C, Mullally B, Ziada H, Allen E & Byrne PJ. (2007).  Periodontitis:2.  Risk 
factors and susceptibility in periodontitis.  Dental Update, 34(5), 270-2,275-6. 
 
Ismail AI, Burt BA & Eklund SA. (1983).  Epidemiologic patterns of smoking and 
periodontal disease in the United States.  Journal of the American Dental 
Association, 106, 617-621.   
 
 
 
 
 60 
 
Kibayashi M, Tanaka M, Nishida N, Kuboniwa M, Kataoka K, Nagata H, 
Nakayama K, Morimoto K & Shizukuishi S. (2007).  Smoking / Periodontitis.  
Journal of Periodontology, 28(5), 859-67. 
 
Kilpatrick ES, Rumley AG, Dominiczak MH & Small M. (1994). Glycated 
haemoglobin values: Problems in assessing blood glucose in diabetes mellitus. 
British Medical Journal. 309, 983-986. 
 
Kinane DF & Chestnutt IG. (1997).  Relationship of diabetes to periodontitis.  
Current opinion in Periodontology, 4, 29-34. 
  
Kinane DF & Chestnutt IG. (2000).  Smoking and Periodontal disease.  Crit Rev 
Oral Biol Med 2000, 11, 356-365.  
 
Kiran M, Arpak N, Unsal E & Erdogan M. (2005).  The effect of improved 
periodontal health on metabolic control in Type II diabetes mellitus.  Journal of 
Clinical Periodontology,32, 266-272.   
 
Koro CE, Bowlin SJ, Bourgeois N & Fedder DO. (2004).  Glycaemic control from 
1988 to 2000 among U.S. adults diagnosed with Type II diabetes .  A preliminary 
report.  Diabetes Care, 27, 17-20. 
 
Laakso M & Pyorala K. (1985).  Age at onset and type of diabetes.  Diabetes 
care, 8, 114-117. 
Lerner UH. (2006).  Inflammation-induced bone remodeling in periodontal 
disease and the influence of post-menopausal osteoporosis.  Journal of Dental 
Research, 85(7), 596-607.  
 
 
 
 
 
 61 
Levitt N.S & Bradshaw D. (2006).  The impact of HIV/ AIDS on Type II diabetes 
prevalence and diabetes healthcare needs in South Africa: projections for 2010.  
Diabetic Medicine, 23, 103-104. 
 
Loe H. (1967).  The Gingival Index, the Plaque Index and Retention Index 
systems. Journal of Periodontology, 38, 610-616. 
 
Loe H. (1993).  Periodontal Disease:  The sixth complication of diabetes mellitus. 
Diabetes Care, 16 (1), 329-334. 
 
Machtei EE. (1992).  Clinical criteria for the definition of 'Established 
Periodontitis.' Journal of Periodontology, 63, 207-215. 
 
Manfredi M, McCullough MJ, Vescovi P, Al-Kaarawi ZM & Porter SR. (2004).  
Update on diabetes mellitus and related oral diseases.  Oral diseases, 10, 187-
200. 
 
Marshall-Day CD, Stephens RG & Quigley LF. (1955).  Periodontal disease 
prevalence and incidence.  Journal of Periodontology, 26, 185-203. 
  
Matu NK,Stephen L,Lalloo R(2009)Prevalence and Severity of Periodontal 
Disease:Type 2 Diabetics versus Non-diabetics.  South African Dental Journal 
2009 .Vol 64sss 
 
Mollentze WF & Levitt NS. (2006). Diabetes mellitus and impaired glucose 
tolerance in South Africa.  In: Chronic Diseases of Lifestyle in South Africa: 1995-
2005.  Steyn K, Fourie J, Temple N (eds).  MRC Technical Report, 2006:  109-
121.   
 
Motala AA, Pirie FJ, Gouws E, Amod A & Omar MAK. (2003).  High incidence of 
Type II diabetes mellitus in South African Indians: a 10 year follow- up study.  
Diabetic Medicine,20, 23-30.  
 
 
 
 
 
 62 
Mealey BL & Oates TW. (2006).  Diabetes Mellitus and Periodontal Diseases.  
Journal of Periodontology, 77, 1289-1303.  
 
Mealey BL & Ocampo GL. (2007).  Diabetes Mellitus and periodontal disease.  
Periodontology 2000, 44, 127-153.  
 
Meurman JH, Sanz M & Janket SJ. (2004).  Oral health, atherosclerosis, and 
cardiovascular disease.  Critical Review of Oral Biol Med, 15, 403-413.  
 
Michalowicz BS, Diehl SR, Gunsolley JC, Sparks BS, Brooks CN, Koertge TE, 
Califano JV, Burmeister JA & Schenkein HA. (2001). Evidence for substantial 
genetic basis for risk of adult periodontitis.  Journal of Clinical Periodontology, 71, 
1699-1707.    
 
Milward M.R & Chapple ILC. (2003).  Classification of Periodontal Diseases: 
Where were we? Where are we now? Where are we going?  Dental Update, 30, 
37-44. 
 
Mirbod SM, Abing SL & Pruthi VK. (2001).  Immunohistochemical study of 
vestibular gingival blood vessel density and internal circumference in smokers 
and no-smokers.  Journal of Clinical Periodontology, 72, 1318-1323. 
 
Mokdad AH, Ford ES & Bowman BA. (2001). The continuing increase in diabetes 
in the U.S.  Diabetes Care, 24, 412. 
 
Muller HP, Stadermann S & Heinecke A. (2001).  Bleeding on probing in smokers 
and non-smokers in a steady state plaque environment.  Clinical Oral 
Investigations, 5, 177-184. 
  
Navarro-Sanchez AB, Faria-Almeida R & Bascones-Martinez A. (2007).  Effect of 
non-surgical periodontal therapy on clinical and immunological response and 
 
 
 
 
 63 
glycaemic control in Type II diabetic patients with moderate periodontitis.  Journal 
of Clinical Periodontology, 34, 835-843. 
 
Nassar H, Kantarci A & Van Dyke TE. (2007).  Diabetic periodontitis a model for 
activated innate immunity and impaired resolution of inflammation.  
Periodontology 2000, 43, 233-244.  
 
Nelson RG, Shlossman M, Budding LM, Pettitt DJ, Saad MF, Genco RJ & 
Knowler W.(1990)  Periodontal disease and NIDDM in Pima Indians. Diabetes 
Care, 13, 836-840. 
Persson RE, Hollender LG, MacEntee MI, Wyatt CC, Kiyak HA & Persson GR. 
(2003). Assessment of periodontal conditions and systemic disease in older 
subjects. Focus on diabetes mellitus. Journal of Clinical Periodontology,30: 207-
213.      
 
Phipps KR, Chan BK, Madden TE, Geurs NC, Reddy MS, Lewis CE & Orwoll ES. 
(2007).  Longitudinal study of bone density and periodontal disease in men.  
Journal of Dental Research, 86(11), 1110-4. 
 
Promsudthi A, Pimapansri S, Deerochanawong C & Kanchanavasita W. (2005).  
The effect of periodontal therapy on uncontrolled Type II diabetes mellitus in 
older subjects.  Oral Diseases, 11, 293-298. 
 
Ramfjord SP. (1967).  Periodontal Disease Index (PDI). Journal of 
Periodontology, 38, 602-610. 
 
Rhodes CJ. (2005).  Type II diabetes - a matter of ß-cell life and death? Science 
2005: 307: 380-384. 
 
Rohlfing Wiedmeyer HM, Little RR, England JD, Tennill A & Goldstein DE. 
(2002).  Defining the relationship between plasma glucose and HbA1c: analysis 
 
 
 
 
 64 
of glucose profiles and HbA1c in the Diabetes Control and Complications Trial.  
Diabetes Care, 25, 275-278.  
 
Ronderos M, Pihlstrom BL & Hodges JS (2001).  Periodontal disease amongst 
indigenous people in the Amazon rain forest.  Journal of Clinical Periodontology, 
28, 995-1003. 
 
Saremi MD, Nelson RG, Tulloch-Reid M, Hanson RL, Sievers ML, Taylor GW, 
Shlossman M, Bennett PH, Genco R & Knowler WC. (2005).  Periodontal 
Disease and Mortality in Type II Diabetes.  Diabetes Care, 28, 27-32. 
 
Shlossman M, Knowler WC, Pettitt DJ & Genco RJ. (1990).  Type II diabetes 
mellitus and periodontal disease.  Journal of American Dental Association, 121, 
532-536.  
 
Socransky Haffajee AD, Cugini MA, Smith C & Kent RL Jr. (1998).  Microbial 
complexes in subgingival plaque.  Journal of Clinical Periodontology, 25(2), 134-
44. 
 
Southerland JH, Taylor GW, Moss K, Offenbacher JD & Offenbacher S. (2006).  
Commonality in chronic inflammatory diseases: periodontitis, diabetes, and 
coronary artery disease.  Periodontology 2000, 40, 130-143. 
 
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC & Pettitt 
DJ. (1996).  Severe Periodontitis and Risk for Poor Glycemic  
Control in Patients with Non-Insulin-Dependent Diabetes Mellitus.  Journal of 
Periodontology, 1085-1092. 
 
Taylor GW, Burt BA, Becker MP, Genco RJ & Shlossman M. (1998). Glycaemic 
control and alveolar bone loss progression in Type II diabetes. Annals of 
Periodontology,3, 30-39. 
 
 
 
 
 65 
 
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC & Pettitt 
DJ. (1998). Non-insulin dependent diabetes mellitus and alveolar bone loss 
progression over 2 years.  Journal of Periodontology, 69, 76-83. 
 
Taylor GW. (2001). Bidirectional Interrelationships between Diabetes and 
Periodontal Diseases.  Annals of Periodontology, 6 (1), 99-110. 
 
Teng YA, Taylor GW, Scannapieco F, Kinane DF, Curtis M, Beck JD & Kogon S, 
(2002).  Periodontal health and systemic disorders.  Journal of Canadian Dental 
Association, 68, 188-192.   
 
Tervonen T & Knuuttila M. (1986). Relation of diabetes control to periodontal 
pocketing and alveolar bone level. Oral Surgery, Oral Medicine and Oral 
Pathology, 61(4), 346-349. 
   
Tomar SL & Asma S. (2000).  Smoking-attributable periodontitis in the United 
States; findings from NHANES III.  National Health and Nutrition Examination 
Survey.  Journal of Periodontology, 71, 743-751.  
 
Tsai C, Hayes C & Tailor GW. (2002).  Glycaemic control of Type II diabetes and 
severe periodontal disease in the US adult population.  Community Dentistry and 
Oral Epidemiology, 30, 182-192. 
 
Van Dyke TE & Serhan CN. (2003).  Resolution of inflammation: a new paradigm 
for the pathogenesis of periodontal diseases.  Journal of Dental Research, 82, 
82-90.  
 
Van Dyke TE & Dave S. (2005).  Risk factors for Periodontitis.  J Int Acad 
Periodontology. 7(1): 3-7.  
 
 
 
 
 
 66 
Virtue MA, Furne JK, Nuttall FQ & Levitt MD. (2004).  Relationship between GHb 
concentration and erythrocyte survival determined from breath carbon monoxide 
concentration.  Diabetes Care, 27, 931-935. 
 
Weatherspoon LJ, Kumanyika SK, Ludlow R & Schatz D. (1994).  Glycaemic 
control in a sample of black and white clinic patients with NIDDM.  17, 1148-53.  
 
Winer M & Sowers JR. (2004).  Epidemiology of Diabetes.  Journal of Clinical 
Pharmacology, 
 
Zimmet PZ, McCarty DJ & de Courten MP. (1997). The global epidemiology of 
non-insulin dependent diabetes mellitus and the metabolic syndrome.  Journal of 
Diabetic Complications, 11, 60-68. 
 
 
 
 
 
 
 
 67 
Appendix I 
 
CONSENT FORM FOR PARTICIPATION IN RESEARCH PROJECT 
 
Title of the Project:  The prevalence and severity of periodontal disease in Type II diabetics. 
 
Names of Researchers: Dr James Hyslop (Principal investigator), Prof L Stephen (Clinical co-
ordinator). 
  
If you would like to participate in this study please tick the relevant boxes: 
 
1.  Have you read and understood the attached information sheet?  
       
2.  Has the purpose of the research project been explained to you?    
 
      
3.  Do you understand the method of sample collection and the risks involved?   
 
 
4.  Do you grant permission for information from your medical records to be disclosed to the 
research team as     
     and when necessary?    
 
5.  Do you agree that data collected for research can be stored for possible use in future research 
projects conducted by the above named researchers and /or other research collaborators?  
 
 
I declare that my participation in this research project is voluntary and that I am free to withdraw 
from the study at any stage or my approval for use of the sample(s) at any time without giving a 
reason and without my medical treatment or legal rights being affected.   I understand that any 
information contained in my file will remain confidential and that I (or my doctor) will be 
informed if any of the results of the medical tests done (as part of the research) have implications 
for my health.  I know how to contact members of the research team should I change my mind 
about participating in this study.    
 
……………………………….  ……………………….  …………………… 
Name of patient    Date    Signature 
(BLOCK CAPITALS) 
 
 
…………………………………. ………………………… ……………………… 
Name of person taking consent  Date    Signature 
 
…………………………………  ………………………… ……………………… 
Name of researcher    Date    Signature 
THANK YOU FOR AGREEING TO PARTICIPATE IN THIS RESEARCH – IT  
IS MUCH APPRECIATED 
 
NO 
YES
S 
NO 
NO YES
S 
NO YES
S 
YES
SS
sS 
NO 
YES 
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ADDENDUM A 
INFORMATION SHEET 
 
Prospective participants are requested to read this information sheet carefully and to ask 
questions if anything is not clear, before signing the attached consent form.  This sheet must 
be detached and retained by the participant and the consent form filed in the record.   
  
The purpose of the research project is to compare the periodontal disease present among poorly 
controlled and controlled Type II diabetic patients attending the diabetes clinic in the Tygerberg 
hospital.  The literature suggests that Type II Diabetes may predispose to periodontal (gum) 
disease.   
The dentist will examine your mouth.  Patients will be asked questions about their dental and 
medical health and also some aspects of their lifestyle history.  All diabetic patients will have 
blood taken for purposes of laboratory investigations of their blood sugar levels; HbA1c 
recording in order to categorize them accordingly. 
 
The examination of the mouth will use oral clinical indices in making a clinical diagnosis of 
periodontal disease; it will be carried out by a dentist. The clinical measurements are painless, 
non-invasive and safe and will be carried out with the utmost care to ensure the comfort of the 
patient. 
 
It must be brought to the attention of the individual that periodontal disease may present with 
bleeding gums and that any bleeding during the procedure may therefore be due to this condition 
(as happens during tooth brushing) and not due to injury inflicted by the dental examiner. The 
bleeding is usually of short duration and will pose no major threat or discomfort to the individual.  
If the gums are healthy, no bleeding will occur.  
 
Patients are required to sign the attached form to be able to participate in the study, thereby 
granting consent for the above-mentioned procedures to be carried out, for the subsequent use of 
the clinical parameters recorded.  The patient will also be required to grant permission for his/her 
other medical history to be disclosed. Participants will be coded by a number and not be recorded 
by name, and information will also be coded to protect the identity of the individual. However, 
the coding will be used by the clinic to trace the individual if relevant medical information (as a 
result of the study) needs to be passed to him/her or his/her doctor.  Where necessary, participants 
with severe periodontal disease will be referred for treatment. 
 
Participation in this study is voluntary and refusal to participate will not prejudice the treatment 
of the patient in any way.  Consent to participate will be recorded by completing the attached 
form.  Should individuals agree to participate and later change their minds, they may withdraw 
from the study at any time by calling: Dr James Hyslop, University of the Western Cape, 
Department of Oral Medicine and Periodontology, Tel: 021 9373000, or email:  
jimhyslop@hotmail.com 
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Appendiks 1 
Instemmingsvorm tot deelname aan navorsingsprojek 
 
Titel van die Projek: Die algemeenheid en felheid  van die periodentale siekte in tipe II 
diabeties. 
 
Name van Navorsers: Dr. James Hyslop (Hoof navorser), Prof. L Stephen (Kliniese 
koördineerder) 
  
As u wil deelneem aan die studie, tik asseblief die relevante blok: 
1.      Het u die aangehegde informasie gelees en verstaan? 
       
2.      Is die rede vir die navorsingsprojek aan u verduidelik? 
      
3.       Verstaan u die metode waardeur die monsters bymekaargemaak gaan word  en die  
          risiko’s daaraan verbonde? 
      
4.      Gee u toestemming dat inligting vanaf u mediese verslae aan die navorsingspan  
         bekend gemaak mag word soos en wanneer dit nodig is?  
5.      Stem u in dat data wat tydens die navorsing ingesamel word gestoor mag word vir 
moontlike toekomstige navorsingsprojekte wat deur die bovermelde navorsers en/of 
ander navorsers-medewerkers gedoen mag word. 
Ek verklaar dat my deelname aan hierdie navorsingsprojek vrywillig is en dat ek die vryheid het 
om op enige stadium van die studie te onttrek of my instemming om monsters te neem enige tyd 
mag staak sonder om ’n rede te verskaf en sonder dat  my mediese regte en dienste beïnvloed sal 
word. Ek verstaan dat enige informasie soos in my mediese lêer vervat, vertroulik sal bly en dat 
ek (of my Dokter) in kennis gestel sal word indien die mediese toetse enige implikasies op my 
gesondheid het.  Ek weet hoe om die lede van die navorsingspan te kontak indien ek van besluit 
verander oor my deelname aan die navorsing. 
………………………………. ……………………….                  …………………… 
Naam van pasiënt               Datum                                Handtekening        
(HOOF BLOKLETTERS) 
 
…………………………………. …………………………                …………………… 
         Naam van persoon                        Datum                 Handtekening  
 wie toestemming gee 
………………………………… …………………………      …………………… 
     Naam van Navorsers            Datum             Handtekening 
 
 
DANKIE VIR U INSTEMMING TOT DEELNAME AAN HIERDIE NAVORSING – DIT 
WORD BAIE WAARDEER. 
 
 
JA NEE 
JA NEE 
JA NEE 
JA NEE 
JA NEE 
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BYLAAG A 
INLIGTINGSBLAD 
 
 
Voornemende deelnemers word versoek om die inligtingsblad deeglik deur te lees en om 
vrae te vra indien daar enigiets is wat onduidelik is, voordat die aangehegde 
instemmingsvorm onderteken word.  Hierdie blad moet losgemaak en gehou word deur die 
deelnemer en die instemmingsvorm word in die verslag geliasseer.    
  
Die doel van die navorsingsprojek is om die periodentale siekte wat voorkom tydens swak 
beheerde diabete te vergelyk met die van tipe II diabeties by pasiënte wat die diabetiese kliniek 
by Tygerberg hospitaal besoek. Die literatuur stel voor dat tipe II diabeties pasiënte moontlik 
meer vatbaar maak vir periodentale (tandvleis) siekte. 
Die tandarts sal u mond ondersoek. Daar sal vrae aan pasiënte gevra word oor hulle mond- en 
mediese gesondheid en ook seker aspekte van hulle lewenstyl gesiedenis. Daar sal bloed getrek 
word van alle diabetiese pasiënte, vir laboratoriumondersoeke na hulle bloedsuikervlakke; HbA1c 
opname ten einde die bloed te kategoriseer.    
Die ondersoek van die mond  sal mond-kliniese aanwysings gebruik vir die maak van ŉ kliniese 
diagnose van die periodentale siekte; dit sal deur ’n tandarts uitgevoer word.  Die kliniese 
meetings is pynloos, ingreepvry en veilig en sal met die grootste sorg uitgevoer word om die 
pasiënt se gemak te verseker.   
Dit moet onder die aandag van die individu gebring word dat periodentale siekte mag lei tot 
bloeiende tandvleis en dat die bloeding tydens die prosedure moontlik as gevolg van die toestand 
is (soos wat gebeur tydens tandeborsel) en nie as gevolg van die besering wat toegedien word 
deur die tandondersoeker nie.  Die bloeding is gewoonlik van korte duur en sal geen groot gevaar 
of ongemak vir die individu inhou nie.  As die tandvleis gesond is, sal geen bloeding voorkom 
nie.  
Ten einde deel te neem aan die studie word daar van pasiënte verwag om die aangehegde vorm te 
onderteken.  Daardeur word ingestem dat die bovermelde prosedure uitgevoer mag word, en dat 
die gevolglike kliniese parameters gedokumenteer mag word.  Daar sal ook van die pasiënt 
verwag word om toestemming te verleen dat sy/haar ander mediese geskiedenis bekendgemaak 
mag word.  Deelnemers sal gekodeer word deur middel van ŉ nommer en nie deur middel van 
hulle naam nie, en inligting sal ook so gekodeer word dat die identiteit van die individu beskermd 
bly.  Die kodering sal egter deur die kliniek gebruik word indien ŉ individu opgespoor moet word 
ten einde relevante mediese inligting (as ŉ resultaat van die studie) aan hom/haar of sy/haar 
dokter deur te gee.  Indien nodig sal deelnemers met ernstige periodentale siekte verwys word vir 
behandeling.  
Deelname aan hierdie studie is vrywillig en weiering om deel te neem sal geen nadelige invloed 
op die behandeling van die pasiënt hê nie.  Instemming tot deelname word bevestig deur die 
voltooiing van die aangehegde vorm.  Sou individue instem om deel te neem en op ŉ later 
stadium van plan verander, mag hulle op enige tydstip van die studie onttrek deur Dr. James 
Hyslop van die Universiteit van die Wes-Kaap, Departement van Orale Medisyne en 
Periodentologie te kontak.  Die telefoon nommer is 021 9373000 en e-pos: 
jimhyslop@hotmail.com 
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Appendix II 
 
QUESTIONNAIRE – INTERVIEW 
 
Date……………………………........... ...                Hospital No……………… 
Study No……………………….. ............          
Name…………………………………….                Race: 1) White  (    ) 
2) Black              (    ) 
Age (years)……………………                               3) Coloured        (    ) 
            4) Indian             (    ) 
Sex: male (    ) female (    )                                5) Other              (    ) 
Occupation…………………………………                                       
 
Residence………………………………..         Duration (years)…………. 
Income per month (In rands):  
1. 0-499 (    ) 2. 500-2399(    ) 3. 2400-5000 (    ) 4. >5000 (    ) 
 
DENTAL HISTORY 
1.    What do you think about the condition of your gums?  
       a. Excellent (    ) b. Very good (    ) c. good (    ) d. poor (    ) 
 
2.    Have you visited a dentist in the last: a. 6 months (    ) b. 1 year (    ) c. 2 years (    )          
       d. never (    ) 
       If yes to the above, what treatment was given? 
       Oral hygiene advice including tooth brushing instruction (    ) 
       Scaling and prophylaxis (    ) 
       Other (specify)……………………………………………………….. 
 
 
 
 
 72 
3.    Do you brush your teeth?    Yes (    )         No (    )  
       If yes: 
       How often do you brush your teeth every day? 
 Once (    )    Twice (    )    
Other (please specify)……………………………………………………………… 
 
4.    Do you employ any other method of cleaning your teeth? 
       If yes, which one.......................................................................................................      
 
MEDICAL HISTORY  
1.     Besides diabetes do you suffer from any chronic illness? 
        Yes (    )     No (    )  
        If yes, specify the condition………………………………. 
  
2.     Last menstrual period where applicable………………......  
        Pregnant:   Yes (    )    No (    ) 
 
3.     Are you on any medication?   Yes (    )   No (    ) 
        If on medication (specify) a) Type………… 
                                                  b) Duration…………… 
 
SOCIAL HISTORY 
1.     Do you use tobacco?    Yes (    )   No (    ) 
 
2.     Do you drink alcohol?     Yes (    )   No (    ) 
        If yes please specify: 
 a. Type/form………………………………………………………………………... 
          b. Amount in a 1) Day………………… 
   2) Week………………. 
   3) Month……………… 
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3.     Please indicate level of education: 
         a. Never attended school  (    ) 
         b. Primary school education  (    ) 
         c. High school               (    ) 
         d. College   (    ) 
         e. University   (    ) 
 
TYPE II DIABETES MELLITUS HISTORY (To be completed by a       
                                                                           Diabetologist) 
 
Control (past 18months), HbA1C (last 3 readings) - 
                                                                                  - 
                                                                                  -                       Mean of last 3 readings 
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Appendix IV 
 
Plaque index (P11) by Loe, 1967 
 
0 = No plaque in the gingival area 
 
1= A film of plaque adhering to the free gingival margin and the adjacent area of the 
tooth. The plaque may only be recognized by running a probe across the tooth surface. 
 
2 = Moderate accumulation of soft deposits within the gingival pocket, on the gingival 
margin and/or adjacent tooth surface, which can be seen by the naked eye. 
 
3 = Abundance of soft matter within the gingival pocket and/or on the gingival margin 
and adjacent tooth surface. 
 
 
 
 
Appendix V 
 
Gingival index (G1) as illustrated in Loe, 1967 
 
0 = Normal Gingival 
 
1 = Mild inflammation – slight change in colour, slight oedema.No bleeding on probing. 
 
2 = Moderate inflammation – redness oedema and glazing.Bleeding on probing. 
 
3 = Severe inflammation – marked redness and oedema.Ulceration. Tendency to 
spontaneous bleeding. 
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